Back to Journals » OncoTargets and Therapy » Volume 9

OncoTargets and Therapy


Archive: Volume 9, 2016

Non-secretory multiple myeloma: from biology to clinical management

Dupuis MM, Tuchman SA

OncoTargets and Therapy 2016, 9:7583-7590

Published Date: 15 December 2016

Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives

Mulet-Margalef N, Garcia-del-Muro X

OncoTargets and Therapy 2016, 9:7573-7582

Published Date: 15 December 2016

Lipopolysaccharide-induced α-catenin downregulation enhances the motility of human colorectal cancer cells in an NF-κB signaling-dependent manner

Cheng G, Yang S, Zhang G, Xu Y, Liu X, Sun W, Zhu L

OncoTargets and Therapy 2016, 9:7563-7571

Published Date: 14 December 2016

Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role

Cochetti G, Poli G, Guelfi G, Boni A, Egidi MG, Mearini E

OncoTargets and Therapy 2016, 9:7545-7553

Published Date: 13 December 2016

The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning

Zhu J, Simon A, Haigron P, Lafond C, Acosta O, Shu H, Castelli J, Li B, De Crevoisier R

OncoTargets and Therapy 2016, 9:7537-7544

Published Date: 12 December 2016

A pilot study employing hepatic intra-arterial irinotecan injection of drug-eluting beads as salvage therapy in liver metastatic colorectal cancer patients without extrahepatic involvement: the first southern Italy experience

Ranieri G, Niccoli Asabella A, Altini C, Fazio V, Caporusso L, Marech I, Vinciarelli G, Macina F, de Ceglia D, Fanelli M, Ammendola M, Rubini G, Gadaleta CD

OncoTargets and Therapy 2016, 9:7527-7535

Published Date: 12 December 2016

β-Elemene treatment of glioblastoma: a single-center retrospective study

Ma C, Zhou W, Yan Z, Qu M, Bu X

OncoTargets and Therapy 2016, 9:7521-7526

Published Date: 12 December 2016

Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells

Souza e Silva V, Chinen LTD, Abdallah EA, Damascena A, Paludo J, Chojniak R, Dettino ALA, Mello CAL, Alves VS, Fanelli MF

OncoTargets and Therapy 2016, 9:7503-7513

Published Date: 13 December 2016

Overexpression and clinical significance of MYC-associated zinc finger protein in pancreatic carcinoma

Zhu X, Luo W, Liang W, Tang F, Bei C, Ren Y, Qin L, Tan C, Zhang Y, Tan S

OncoTargets and Therapy 2016, 9:7493-7501

Published Date: 12 December 2016

Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells

Ye T, Su J, Huang C, Yu D, Dai S, Huang X, Chen B, Zhou M

OncoTargets and Therapy 2016, 9:7481-7492

Published Date: 12 December 2016

Biomarkers in pancreatic adenocarcinoma: current perspectives

Swords DS, Firpo MA, Scaife CL, Mulvihill SJ

OncoTargets and Therapy 2016, 9:7459-7467

Published Date: 9 December 2016

Comparison of the clinical features and hematopoietic stem cell transplantation outcomes of mediastinal malignant germ cell tumors with nonmediastinal extragonadal placements

Ocal N, Yildiz B, Karadurmus N, Dogan D, Ozaydin S, Ocal R, Ozturk M, Arpaci F, Bilgic H

OncoTargets and Therapy 2016, 9:7445-7450

Published Date: 9 December 2016

Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population

Yan WY, Hu J, Xie L, Cheng L, Yang M, Li L, Shi J, Liu BR, Qian X

OncoTargets and Therapy 2016, 9:7415-7424

Published Date: 8 December 2016

Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis

Shi H, Wang X, Wang J, Pan J, Liu J, Ye B

OncoTargets and Therapy 2016, 9:7409-7414

Published Date: 8 December 2016

Identification of feature genes for smoking-related lung adenocarcinoma based on gene expression profile data

Liu Y, Ni R, Zhang H, Miao L, Wang J, Jia W, Wang Y

OncoTargets and Therapy 2016, 9:7397-7407

Published Date: 7 December 2016

Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran

Dolatkhah R, Somi MH, Asvadi Kermani I, Bonyadi M, Sepehri B, Boostani K, Azadbakht S, Fotouhi N, Farassati F, Dastgiri S

OncoTargets and Therapy 2016, 9:7385-7395

Published Date: 7 December 2016

Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway

Kang Y, Hu W, Bai E, Zheng H, Liu Z, Wu J, Jin R, Zhao C, Liang G

OncoTargets and Therapy 2016, 9:7373-7384

Published Date: 5 December 2016

Mutations in hepatitis B virus small S genes predict postoperative survival in hepatocellular carcinoma

Peng L, Yang G, Wu C, Wang WS, Wu J, Guo Z

OncoTargets and Therapy 2016, 9:7367-7372

Published Date: 2 December 2016

Next-generation sequencing: advances and applications in cancer diagnosis

Serratì S, De Summa S, Pilato B, Petriella D, Lacalamita R, Tommasi S, Pinto R

OncoTargets and Therapy 2016, 9:7355-7365

Published Date: 2 December 2016

Structure–activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches

Lakhlili W, Yasri A, Ibrahimi A

OncoTargets and Therapy 2016, 9:7345-7353

Published Date: 2 December 2016

History and progression of Fat cadherins in health and disease

Zhang X, Liu J, Liang X, Chen J, Hong J, Li L, He Q, Cai X

OncoTargets and Therapy 2016, 9:7337-7343

Published Date: 1 December 2016

Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel

Khosravian P, Shafiee Ardestani M, Khoobi M, Ostad SN, Dorkoosh FA, Akbari Javar H, Amanlou M

OncoTargets and Therapy 2016, 9:7315-7330

Published Date: 1 December 2016

Long-term benefit of sunitinib in patients with metastatic renal cell carcinoma in Latin America: retrospective analysis of patient clinical characteristics

Smaletz O, Chacón M, de Oliveira Koch L, de Carvalho Rocha DR, Cardoso FC

OncoTargets and Therapy 2016, 9:7309-7314

Published Date: 30 November 2016

Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1

Zhang J, Fu J, Pan Y, Zhang X, Shen L

OncoTargets and Therapy 2016, 9:7297-7307

Published Date: 1 December 2016

CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer

Yang K, Gao K, Hu G, Wen Y, Lin C, Li X

OncoTargets and Therapy 2016, 9:7285-7295

Published Date: 30 November 2016

Androgen deprivation therapy as backbone therapy in the management of prostate cancer

Merseburger AS, Alcaraz A, von Klot CA

OncoTargets and Therapy 2016, 9:7263-7274

Published Date: 29 November 2016

Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression

Xue F, Liu YH, Zhang HW, Wen Y, Yan L, Tang Q, Xiao EH, Zhang DY

OncoTargets and Therapy 2016, 9:7253-7261

Published Date: 28 November 2016

Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives

Davidson M, Starling N

OncoTargets and Therapy 2016, 9:7235-7245

Published Date: 25 November 2016

E2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol

Hu YX, He HL, Lu J, Wang Y, Xiao PF, Li JQ, Li J, Sun YN, Lv H, Fan JJ, Yao YH, Chai YH, Hu SY

OncoTargets and Therapy 2016, 9:7219-7225

Published Date: 22 November 2016

Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time

Baek N, Seo OW, Kim M, Hulme J, An SSA

OncoTargets and Therapy 2016, 9:7207-7218

Published Date: 22 November 2016

High expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma

Na N, Si T, Huang Z, Miao B, Hong L, Li H, Qiu J, Qiu J

OncoTargets and Therapy 2016, 9:7199-7205

Published Date: 22 November 2016

Effect of smoking on the genetic makeup of toll-like receptors 2 and 6

Kohailan M, Alanazi M, Rouabhia M, Alamri A, Parine NR, Alhadheq A, Basavarajappa S, Abdullah Al-Kheraif AA, Semlali A

OncoTargets and Therapy 2016, 9:7187-7198

Published Date: 21 November 2016

The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma

Wang J, Wang SZ, Song XM, Zeng WJ, Wang SY, Chen F, Ding H

OncoTargets and Therapy 2016, 9:7177-7185

Published Date: 21 November 2016

Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity

Liang P, Huang C, Liang S, Li Y, Huang S, Lian Z, Liu J, Tang Y, Lu H

OncoTargets and Therapy 2016, 9:7169-7175

Published Date: 18 November 2016

Next-generation sequence detects ARAP3 as a novel oncogene in papillary thyroid carcinoma

Wang QX, Chen ED, Cai YF, Zhou YL, Zheng ZC, Wang YH, Jin YX, Jin WX, Zhang XH, Wang OC

OncoTargets and Therapy 2016, 9:7161-7167

Published Date: 18 November 2016

BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy

Chowdhary M, Patel KR, Danish HH, Lawson DH, Khan MK

OncoTargets and Therapy 2016, 9:7149-7159

Published Date: 12 December 2016

Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus

Wu F, Lu H, Zhu S, Li Z, Zou L, Bai T, Chen J, Yang T, Liang S

OncoTargets and Therapy 2016, 9:7141-7147

Published Date: 1 December 2016

Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells

Xie L, Zhao T, Cai J, Su Y, Wang Z, Dong W

OncoTargets and Therapy 2016, 9:7115-7122

Published Date: 17 November 2016

Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases

Zeng ZM, Luo FF, Zou LX, He RQ, Pan DH, Chen X, Xie TT, Li YQ, Peng ZG, Chen G

OncoTargets and Therapy 2016, 9:7105-7114

Published Date: 17 November 2016

Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial

Harrington KJ, Andtbacka RHI, Collichio F, Downey G, Chen L, Szabo Z, Kaufman HL

OncoTargets and Therapy 2016, 9:7081-7093

Published Date: 16 November 2016

Lrig1 is a positive prognostic marker in hepatocellular carcinoma

Yang B, Dai C, Tan RM, Zhang B, Meng X, Ye J, Wang XQ, Wei L, He F, Chen ZS

OncoTargets and Therapy 2016, 9:7071-7079

Published Date: 15 November 2016

MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1

Xu D, Chen XF, He QY, Luo CQ

OncoTargets and Therapy 2016, 9:7047-7057

Published Date: 15 November 2016

Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer

Yang F, Lv S, Lv L, Liu Y, Dong S, Yao Z, Dai X, Zhang X, Wang O

OncoTargets and Therapy 2016, 9:7039-7045

Published Date: 15 November 2016

ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma

Chen L, Liu MM, Liu H, Lu D, Zhao XD, Yang XJ

OncoTargets and Therapy 2016, 9:7019-7028

Published Date: 14 November 2016

CT-diagnosed severe skull base bone destruction predicts distant bone metastasis in early N-stage nasopharyngeal carcinoma

Yi W, Liu ZG, Li X, Tang J, Jiang CB, Hu JY, Tu ZW, Wang H, Niu DL, Xia YF

OncoTargets and Therapy 2016, 9:7011-7017

Published Date: 14 November 2016

MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1

Hu ZL, Cui YH, Zhou YH, Zhou KY, Qiao XQ, Li CQ, Wang S

OncoTargets and Therapy 2016, 9:6999-7009

Published Date: 14 November 2016

The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis

Zhai R, Tang F, Gong JH, Zhang J, Lei B, Li B, Wei YC, Liang XS, Tang B, He SQ

OncoTargets and Therapy 2016, 9:6987-6998

Published Date: 24 November 2016

Role of p14ARF and p15INK4B promoter methylation in patients with lung cancer: a systematic meta-analysis

Yang X, Yang L, Dai W, Ye B

OncoTargets and Therapy 2016, 9:6977-6985

Published Date: 11 November 2016

Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis

Su X, Jiang X, Wang W, Wang H, Xu X, Lin A, Teng X, Wu H, Teng L

OncoTargets and Therapy 2016, 9:6965-6976

Published Date: 11 November 2016

Comparison of internal target volumes defined on 3-dimensional, 4-dimensonal, and cone-beam CT images of non-small-cell lung cancer

Li F, Li J, Ma Z, Zhang Y, Xing J, Qi H, Shang D

OncoTargets and Therapy 2016, 9:6945-6951

Published Date: 17 November 2016

Paxillin functions as an oncogene in human gliomas by promoting cell migration and invasion

Chen B, Xia L, Xu C, Xiao F, Wang Y

OncoTargets and Therapy 2016, 9:6935-6943

Published Date: 9 November 2016

Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells

Pileczki V, Pop L, Braicu C, Budisan L, Bolba Morar G, del C Monroig-Bosque P, Sandulescu RV, Berindan-Neagoe I

OncoTargets and Therapy 2016, 9:6921-6933

Published Date: 11 November 2016

A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma

Zhao YY, Liu L, Zhou T, Zhou NN, Yang YP, Hou X, Li Y, Zhao HY, Huang Y, Zhang L

OncoTargets and Therapy 2016, 9:6915-6920

Published Date: 8 November 2016

miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial–mesenchymal transition

Zhang XG, Zhang T, Yang K, Zhang MH, Wang KM

OncoTargets and Therapy 2016, 9:6909-6914

Published Date: 8 November 2016

Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection

Zhong JH, Ke Y, Zhu SL, Wang L, Luo CP, Gong WF, You XM, Ma L, Xiang BD, Li LQ

OncoTargets and Therapy 2016, 9:6897-6907

Published Date: 10 November 2016

Genetic variation rs7930 in the miR-4273-5p target site is associated with a risk of colorectal cancer

Lee AR, Park J, Jung KJ, Jee SH, Kim-Yoon SJ

OncoTargets and Therapy 2016, 9:6885-6895

Published Date: 7 November 2016

Hürthle cell carcinoma: current perspectives

Ahmadi S, Stang M, Jiang XS, Sosa JA

OncoTargets and Therapy 2016, 9:6873-6884

Published Date: 7 November 2016

NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells

Zhong Y, Shen S, Zhou Y, Mao F, Lin Y, Guan J, Xu Y, Zhang S, Liu X, Sun Q

OncoTargets and Therapy 2016, 9:6865-6871

Published Date: 7 November 2016

FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma

El-Hamamsy M, Ghali RR, Saad AS, Shaheen SM, Salem AM

OncoTargets and Therapy 2016, 9:6857-6863

Published Date: 7 November 2016

Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma

Jeannot V, Busser B, Vanwonterghem L, Michallet S, Ferroudj S, Cokol M, Coll JL, Ozturk M, Hurbin A

OncoTargets and Therapy 2016, 9:6843-6855

Published Date: 9 November 2016

Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma

Xu Y, Guo Q, Lin J, Chen B, Wen J, Lu T, Xu Y, Zhang M, Pan J, Lin S

OncoTargets and Therapy 2016, 9:6835-6841

Published Date: 4 November 2016

Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management

Wu S, Mo M, Wang Y, Zhang N, Li J, Di G, Shao Z, Wu J, Liu G

OncoTargets and Therapy 2016, 9:6829-6834

Published Date: 4 November 2016

Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening

Iovanescu D, Frandes M, Lungeanu D, Burlea A, Miutescu BP, Miutescu E

OncoTargets and Therapy 2016, 9:6819-6828

Published Date: 4 November 2016

Differentiation between adrenal adenomas and nonadenomas using dynamic contrast-enhanced computed tomography

Wang XF, Li KG, Sun HR, Zhao JL, Zheng LF, Zhang ZL, Bai RJ, Zhang GX

OncoTargets and Therapy 2016, 9:6809-6817

Published Date: 3 November 2016

Association of TIMP-2-418G/C and TIMP-2-303G/A with gastric cancer: a meta-analysis

Yang Y, Xiong Y, Li J, Wu C, Jiang J

OncoTargets and Therapy 2016, 9:6801-6808

Published Date: 3 November 2016

Total versus subtotal gastrectomy for distal gastric cancer: meta-analysis of randomized clinical trials

Kong L, Yang N, Shi L, Zhao G, Wang M, Zhang Y

OncoTargets and Therapy 2016, 9:6795-6800

Published Date: 7 November 2016

Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking

Coppola C, Riccio G, Barbieri A, Monti MG, Piscopo G, Rea D, Arra C, Maurea C, De Lorenzo C, Maurea N

OncoTargets and Therapy 2016, 9:6785-6794

Published Date: 2 November 2016

Cervical nodal necrosis is an independent survival predictor in nasopharyngeal carcinoma: an observational cohort study

Luo Y, Ren J, Zhou P, Gao Y, Yang G, Lang J

OncoTargets and Therapy 2016, 9:6775-6783

Published Date: 1 November 2016

Minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysis

Lv L, Hu WD, Ren YC, Wei XX

OncoTargets and Therapy 2016, 9:6751-6762

Published Date: 31 October 2016

Positive expression of KIF20A indicates poor prognosis of glioma patients

Duan J, Huang W, Shi H

OncoTargets and Therapy 2016, 9:6741-6749

Published Date: 2 November 2016

A current perspective on stereotactic body radiation therapy for pancreatic cancer

Hong JC, Czito BG, Willett CG, Palta M

OncoTargets and Therapy 2016, 9:6733-6739

Published Date: 31 October 2016

Effect of VEGF-C siRNA and endostatin on ring formation and proliferation of esophageal squamous cell carcinoma lymphatic endothelial cells

Zheng YP, Sun MM, Chen JY, He LL, Zhao N, Chen KS

OncoTargets and Therapy 2016, 9:6727-6732

Published Date: 31 October 2016

High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma

Zhang L, Xiu DR, Zhan J, He XK, Guo LM, Wang JL, Tao M, Fu W, Zhang HQ

OncoTargets and Therapy 2016, 9:6719-6726

Published Date: 31 October 2016

Elevated HABP1 protein expression correlates with progression and poor survival in patients with gastric cancer

Gao H, Yao Q, Lan X, Li S, Wu J, Zeng G, Xue Y

OncoTargets and Therapy 2016, 9:6711-6718

Published Date: 31 October 2016

Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis

Chen Z, Shao Y, Wang K, Cao W, Xiong Y, Wu R, Luo S, Xu X, He X

OncoTargets and Therapy 2016, 9:6701-6710

Published Date: 28 October 2016

Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients

Kurtz JE, Soubeyran P, Michallet M, Luporsi E, Albrand H

OncoTargets and Therapy 2016, 9:6689-6693

Published Date: 28 October 2016

Association between prognostic survival of human colorectal carcinoma and ZNRF3 expression

Yu N, Zhu H, Tao Y, Huang Y, Song X, Zhou Y, Li Y, Pei Q, Tan Q, Pei H

OncoTargets and Therapy 2016, 9:6679-6687

Published Date: 28 October 2016

Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis

Artene S, Turcu-Stiolica A, Hartley R, Ciurea ME, Daianu O, Brindusa C, Alexandru O, Tataranu LG, Purcaru SO, Dricu A

OncoTargets and Therapy 2016, 9:6669-6677

Published Date: 4 November 2016

SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer

Komiya K, Nakamura T, Nakashima C, Takahashi K, Umeguchi H, Watanabe N, Sato A, Takeda Y, Kimura S, Sueoka-Aragane N

OncoTargets and Therapy 2016, 9:6663-6668

Published Date: 27 October 2016

The medicinal fungus Antrodia cinnamomea regulates DNA repair and enhances the radiosensitivity of human esophageal cancer cells

Liu YM, Liu YK, Wang LW, Huang YC, Huang PI, Tsai TH, Chen YJ

OncoTargets and Therapy 2016, 9:6651-6661

Published Date: 27 October 2016

Investigation of cyclin D1 rs9344 G>A polymorphism in colorectal cancer: a meta-analysis involving 13,642 subjects

Qiu H, Cheng C, Wang Y, Kang M, Tang W, Chen S, Gu H, Liu C, Chen Y

OncoTargets and Therapy 2016, 9:6641-6650

Published Date: 27 October 2016

MLL1 promotes cervical carcinoma cell tumorigenesis and metastasis through interaction with β-catenin

Qiang R, Cai N, Wang X, Wang L, Cui K, Wang X, Li X

OncoTargets and Therapy 2016, 9:6631-6640

Published Date: 28 October 2016

BCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancer

Zhao H, Wang WL, Zhao QH, Hu GM, Deng KH, Liu YL

OncoTargets and Therapy 2016, 9:6619-6629

Published Date: 26 October 2016

Effective treatment with icotinib in lung adenocarcinoma with EGFR and ALK co-alterations and brain metastasis

Ye CY, Wang J, Zheng S, Chai Y

OncoTargets and Therapy 2016, 9:6605-6608

Published Date: 26 October 2016

The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer

Liu YY, Tu L, Wang L, Long J, Wang J, Wang Y, Luo F, Cao D

OncoTargets and Therapy 2016, 9:6581-6595

Published Date: 25 October 2016

Dysfunction of microRNA-32 regulates ubiquitin ligase FBXW7 in multiple myeloma disease

Hua J, Ding T, Yang L

OncoTargets and Therapy 2016, 9:6573-6579

Published Date: 25 October 2016

Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study

Cai CF, Sun JY, He Z, Lin HX, Liu FR, Wang Y

OncoTargets and Therapy 2016, 9:6569-6572

Published Date: 25 October 2016

Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy in Saudi Arabia

Maklad AM, Bayoumi Y, Senosy Hassan MA, Elawadi AA, AlHussain H, Elyamany A, Aldhahri SF, Al-Qahtani KH, AlQahtani M, Tunio MA

OncoTargets and Therapy 2016, 9:6561-6567

Published Date: 25 October 2016

Cell-free DNA as a diagnostic marker for cancer: current insights

Salvi S, Gurioli G, De Giorgi U, Conteduca V, Tedaldi G, Calistri D, Casadio V

OncoTargets and Therapy 2016, 9:6549-6559

Published Date: 25 October 2016

Novel therapeutic strategies for patients with triple-negative breast cancer

Zhang JF, Liu J, Wang Y, Zhang B

OncoTargets and Therapy 2016, 9:6519-6528

Published Date: 21 October 2016

Snake venom causes apoptosis by increasing the reactive oxygen species in colorectal and breast cancer cell lines

Al-Asmari AK, Riyasdeen A, Al-Shahrani MH, Islam M

OncoTargets and Therapy 2016, 9:6485-6498

Published Date: 20 October 2016

The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China

Xu J, Ding G, Zhang X, Jin B, Lou Y, Zhang Y, Wang H, Wu D, Han B

OncoTargets and Therapy 2016, 9:6479-6484

Published Date: 20 October 2016

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

Lorusso L, Pieruzzi L, Biagini A, Sabini E, Valerio L, Giani C, Passannanti P, Pontillo-Contillo B, Battaglia V, Mazzeo S, Molinaro E, Elisei R

OncoTargets and Therapy 2016, 9:6467-6477

Published Date: 20 October 2016

Dephosphorylated cofilin expression is associated with poor prognosis in cases of human breast cancer: a tissue microarray analysis

Maimaiti Y, Liu ZM, Tan J, Abudureyimu K, Huang BX, Liu CP, Guo YW, Wang CW, Nie X, Zhou J, Huang T

OncoTargets and Therapy 2016, 9:6461-6466

Published Date: 19 October 2016

Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER database

Lin MQ, Li YP, Wu SG, Sun JY, Lin HX, Zhang SY, He ZY

OncoTargets and Therapy 2016, 9:6435-6444

Published Date: 19 October 2016

Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma

Mürtz P, Penner AH, Pfeiffer AK, Sprinkart AM, Pieper CC, König R, Block W, Schild HH, Willinek WA, Kukuk GM

OncoTargets and Therapy 2016, 9:6425-6433

Published Date: 19 October 2016

Biomarker and competing endogenous RNA potential of tumor-specific long noncoding RNA in chromophobe renal cell carcinoma

He HT, Xu M, Kuang Y, Han XY, Wang MQ, Yang Q

OncoTargets and Therapy 2016, 9:6399-6406

Published Date: 18 October 2016

Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma

Sun P, Zhang F, Chen C, Ren C, Bi XW, Yang H, An X, Wang FH, Jiang WQ

OncoTargets and Therapy 2016, 9:6389-6397

Published Date: 17 October 2016

Synergistic suppression effect on tumor growth of ovarian cancer by combining cisplatin with a manganese superoxide dismutase-armed oncolytic adenovirus

Wang S, Shu J, Chen L, Chen X, Zhao J, Li S, Mou X, Tong X

OncoTargets and Therapy 2016, 9:6381-6388

Published Date: 17 October 2016

miR-32 functions as a tumor suppressor and directly targets SOX9 in human non–small cell lung cancer [Retraction]

Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, Yu L

OncoTargets and Therapy 2016, 9:6379-6380

Published Date: 20 October 2016

MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma [Retraction]

Lin FO, Yao LJ, Xiao J, Liu DF, Ni ZY

OncoTargets and Therapy 2016, 9:6377-6378

Published Date: 20 October 2016

Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice

Passaro A, Lazzari C, Karachaliou N, Spitaleri G, Pochesci A, Catania C, Rosell R, de Marinis F

OncoTargets and Therapy 2016, 9:6361-6376

Published Date: 17 October 2016

Cancer: fundamentals behind pH targeting and the double-edged approach

Koltai T

OncoTargets and Therapy 2016, 9:6343-6360

Published Date: 17 October 2016

Rare frequency of gene variation and survival analysis in thymic epithelial tumors

Song Z, Yu X, Zhang Y

OncoTargets and Therapy 2016, 9:6337-6342

Published Date: 14 October 2016

hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy

Muratori L, Petroni G, Antonuzzo L, Boni L, Iorio J, Lastraioli E, Bartoli G, Messerini L, Di Costanzo F, Arcangeli A

OncoTargets and Therapy 2016, 9:6325-6332

Published Date: 14 October 2016

18F-fludrodeoxyglucose maximal standardized uptake value and metabolic tumor burden are associated with major chemotherapy-related tumor markers in NSCLC patients

Bai L, Guo CH, Wang JS, Liu X, Li Y, Li M, Guo YM, Duan XY

OncoTargets and Therapy 2016, 9:6315-6324

Published Date: 14 October 2016

Prognostic value of endocan expression in cancers: evidence from meta-analysis

Huang X, Chen C, Wang X, Zhang JY, Ren BH, Ma DW, Xia L, Xu XY, Xu L

OncoTargets and Therapy 2016, 9:6297-6304

Published Date: 13 October 2016

Primary adenoid cystic carcinoma of the trachea with thyroid invasion: a case report and literature review

Qi D, Feng L, Li J, Liu B, Zhang Q

OncoTargets and Therapy 2016, 9:6291-6296

Published Date: 13 October 2016

Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation

Gong ZJ, Guo W, Sun YF, Zhang X, Qiu SJ, Zhou J, Fan J, Yang XR

OncoTargets and Therapy 2016, 9:6281-6290

Published Date: 13 October 2016

CT-detected solitary thyroid calcification: an important imaging feature for papillary carcinoma

Yang T, Huang Y, Jing X, Gai X, Li W

OncoTargets and Therapy 2016, 9:6273-6279

Published Date: 13 October 2016

Locally advanced rectal cancer: management challenges

Kokelaar RF, Evans MD, Davies M, Harris DA, Beynon J

OncoTargets and Therapy 2016, 9:6265-6272

Published Date: 13 October 2016

Epidermal growth factor receptor and B7-H3 expression in esophageal squamous tissues correlate to patient prognosis

Song J, Shi W, Zhang Y, Sun M, Liang X, Zheng S

OncoTargets and Therapy 2016, 9:6257-6263

Published Date: 12 October 2016

Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas

De Vita A, Mercatali L, Recine F, Pieri F, Riva N, Bongiovanni A, Liverani C, Spadazzi C, Miserocchi G, Amadori D, Ibrahim T

OncoTargets and Therapy 2016, 9:6233-6246

Published Date: 11 October 2016

Differential expression of two activating transcription factor 5 isoforms in papillary thyroid carcinoma

Vicari L, La Rosa C, Forte S, Calabrese G, Colarossi C, Aiello E, Salluzzo S, Memeo L

OncoTargets and Therapy 2016, 9:6225-6231

Published Date: 11 October 2016

Influence of MDM2 polymorphisms on squamous cell carcinoma susceptibility: a meta-analysis

Yu H, Li H, Zhang J, Liu G

OncoTargets and Therapy 2016, 9:6211-6224

Published Date: 11 October 2016

miR-203 facilitates tumor growth and metastasis by targeting fibroblast growth factor 2 in breast cancer

He S, Zhang G, Dong H, Ma M, Sun Q

OncoTargets and Therapy 2016, 9:6203-6210

Published Date: 11 October 2016

Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells

Liu L, Wang ZH, Han J, Tang C, Chen N, Lin Z, Peng PJ

OncoTargets and Therapy 2016, 9:6195-6201

Published Date: 11 October 2016

Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma

Zhu S, Miao CW, Wang ZT, Peng L, Li B

OncoTargets and Therapy 2016, 9:6187-6193

Published Date: 13 October 2016

Invasive atypical thymic carcinoid: three case reports and literature review

Zhu S, Wang Z, Liu W, Zong S, Li B

OncoTargets and Therapy 2016, 9:6171-6176

Published Date: 11 October 2016

miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52

Chen H, Xu H, Meng YG, Zhang Y, Chen JY, Wei XN

OncoTargets and Therapy 2016, 9:6151-6160

Published Date: 11 October 2016

Chemotherapy combined with high-dose extended-field radiotherapy for stage I extranodal nasal-type natural killer/T-cell lymphoma

Luo J, Cao C, Zhu Y, Liu P, Liu L, Lu K, Zhang N, Zhou N

OncoTargets and Therapy 2016, 9:6147-6150

Published Date: 11 October 2016

Prognostic value of microRNA-126 and CRK expression in gastric cancer

Yue S, Shi H, Han J, Zhang T, Zhu W, Zhang D

OncoTargets and Therapy 2016, 9:6127-6135

Published Date: 11 October 2016

Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas

Auezova R, Ryskeldiev N, Doskaliyev A, Kuanyshev Y, Zhetpisbaev B, Aldiyarova N, Ivanova N, Akshulakov S, Auezova L

OncoTargets and Therapy 2016, 9:6111-6117

Published Date: 11 October 2016

Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer

He J, Jin Y, Chen Y, Yao HB, Xia YJ, Ma YY, Wang W, Shao QS

OncoTargets and Therapy 2016, 9:6099-6109

Published Date: 7 October 2016

Primary breast diffuse large B-cell lymphoma in the era of rituximab

Zhang N, Cao C, Zhu Y, Liu P, Liu L, Lu K, Luo J, Zhou N

OncoTargets and Therapy 2016, 9:6093-6097

Published Date: 7 October 2016

Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors

Fan Y, Ma K, Wang C, Ning J, Hu Y, Dong D, Dong X, Geng Q, Li E, Wu Y

OncoTargets and Therapy 2016, 9:6075-6082

Published Date: 6 October 2016

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

Van Der Steen N, Caparello C, Rolfo C, Pauwels P, Peters GJ, Giovannetti E

OncoTargets and Therapy 2016, 9:6065-6074

Published Date: 6 October 2016

Relationships between MGMT promoter methylation and gastric cancer: a meta-analysis

Yu D, Cao T, Han YD, Huang FS

OncoTargets and Therapy 2016, 9:6049-6057

Published Date: 5 October 2016

miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway

Shen B, Yu S, Zhang Y, Yuan Y, Li X, Zhong J, Feng J

OncoTargets and Therapy 2016, 9:6009-6019

Published Date: 3 October 2016

Infliximab enhances the therapeutic effects of 5-fluorouracil resulting in tumor regression in colon cancer

Liu F, Ai F, Tian L, Liu S, Zhao L, Wang X

OncoTargets and Therapy 2016, 9:5999-6008

Published Date: 3 October 2016

CX-5461 induces autophagy and inhibits tumor growth via mammalian target of rapamycin-related signaling pathways in osteosarcoma

Li L, Li Y, Zhao J, Fan S, Wang L, Li X

OncoTargets and Therapy 2016, 9:5985-5997

Published Date: 29 September 2016

Association analysis of DACT1 genetic variants and gastric cancer risk in a Chinese Han population: a case–control study

Huang C, Wang YN, Fan H, Ma X, Tang R, Huan XK, Zhu Y, Xu ZK, Xu H, Yang L

OncoTargets and Therapy 2016, 9:5975-5983

Published Date: 29 September 2016

Expression of OVOL2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma

Fu H, Qi L, Chen L, He Y, Zhang N, Guo H

OncoTargets and Therapy 2016, 9:5963-5973

Published Date: 29 September 2016

Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma

Wei GB, Lu YY, Liao RW, Chen QS, Zhang KQ

OncoTargets and Therapy 2016, 9:5955-5961

Published Date: 28 September 2016

BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects

Abedin SM, Boddy CS, Munshi HG

OncoTargets and Therapy 2016, 9:5943-5953

Published Date: 28 September 2016

MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches

Markowitz J, Abrams Z, Jacob NK, Zhang X, Hassani JN, Latchana N, Wei L, Regan KE, Brooks TR, Uppati SR, Levine KM, Bekaii-Saab T, Kendra KL, Lesinski GB, Howard JH, Olencki T, Payne PR, Carson WE III

OncoTargets and Therapy 2016, 9:5931-5941

Published Date: 29 September 2016

The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study

Jia YX, Li TF, Zhang DD, Fan ZM, Fan HJ, Yan J, Chen LJ, Tang H, Qin YR, Li XY

OncoTargets and Therapy 2016, 9:5919-5929

Published Date: 27 September 2016

Combination of cold atmospheric plasma and iron nanoparticles in breast cancer: gene expression and apoptosis study

Jalili A, Irani S, Mirfakhraie R

OncoTargets and Therapy 2016, 9:5911-5917

Published Date: 28 September 2016

Complications of ultrasound-guided percutaneous microwave ablation of renal cell carcinoma

Dong XJ, Li X, Yu J, Yu MA, Yu XL, Liang P

OncoTargets and Therapy 2016, 9:5903-5909

Published Date: 26 September 2016

Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study

Wang Y, Sun XR, Feng WM, Bao Y, Zheng YY

OncoTargets and Therapy 2016, 9:5897-5902

Published Date: 26 September 2016

Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification

Ren T, Lin SD, Wang ZF, Shang AJ

OncoTargets and Therapy 2016, 9:5883-5895

Published Date: 27 September 2016

Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy

Wang L, Bi XW, Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ

OncoTargets and Therapy 2016, 9:5875-5881

Published Date: 26 September 2016

The efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials

Huang J, Zhang Y, Sheng J, Zhang H, Fang W, Zhan J, Zhou T, Chen Y, Liu L, Zhang L

OncoTargets and Therapy 2016, 9:5867-5874

Published Date: 23 September 2016

Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date

Vachhani P, Chen H

OncoTargets and Therapy 2016, 9:5855-5866

Published Date: 23 September 2016

Nanoradiopharmaceuticals for breast cancer imaging: development, characterization, and imaging in inducted animals

Sarcinelli MA, Albernaz MS, Szwed M, Iscaife A, Leite KRM, Junqueira MS, Bernardes ES, da Silva EO, Tavares MIB, Santos-Oliveira R

OncoTargets and Therapy 2016, 9:5847-5854

Published Date: 23 September 2016

Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma

Barrios CH, Herchenhorn D, Chacón M, Cabrera-Galeana P, Sajben P, Zhang K

OncoTargets and Therapy 2016, 9:5839-5845

Published Date: 23 September 2016

An evaluation of the diagnostic efficacy of fine needle aspiration biopsy in patients operated for a thyroid nodular goiter

Janczak D, Pawlowski W, Dorobisz T, Janczak D, Dorobisz K, Leśniak M, Ziomek A, Chabowski M

OncoTargets and Therapy 2016, 9:5819-5823

Published Date: 22 September 2016

Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors

Yıldız Y, Sokmensuer C, Yalcin S

OncoTargets and Therapy 2016, 9:5809-5817

Published Date: 22 September 2016

Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer

Xing J, Luo Y, Wang X, Gao M, Sun M, Ding X, Fan T, Yu J

OncoTargets and Therapy 2016, 9:5803-5808

Published Date: 22 September 2016

A clear cell adenocarcinoma of the gallbladder with hepatoid differentiation: case report and review of literature

Zhang C, Zhang W, Mu D, Shi X, Zhao L

OncoTargets and Therapy 2016, 9:5797-5802

Published Date: 22 September 2016

Prognostic value of decreased microRNA-133a in solid cancers: a meta-analysis

Xiao J, Zou Y, Lu X, Xie B, Yu Q, He B, He B, Chen Q

OncoTargets and Therapy 2016, 9:5771-5779

Published Date: 21 September 2016

Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer

Wang X, Teng F, Kong L, Yu J

OncoTargets and Therapy 2016, 9:5761-5770

Published Date: 20 September 2016

The expression of NEDD9 and E-cadherin correlates with metastasis and poor prognosis in triple-negative breast cancer patients

Li P, Sun T, Yuan Q, Pan G, Zhang J, Sun D

OncoTargets and Therapy 2016, 9:5751-5759

Published Date: 19 September 2016

The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer

Jiang HC, Chen CS, Sun QM, Wu J, Qiu LJ, Gao CE, Liu WQ, Yang J, Jun N, Dong J

OncoTargets and Therapy 2016, 9:5737-5750

Published Date: 26 September 2016

Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study

Chen XR, Liang JZ, Ma SX, Fang WF, Zhou NN, Liao H, Li DL, Chen LK

OncoTargets and Therapy 2016, 9:5729-5736

Published Date: 19 September 2016

Proton beam therapy: clinical utility and current status in prostate cancer

Yamoah K, Johnstone PA

OncoTargets and Therapy 2016, 9:5721-5727

Published Date: 16 September 2016

A negative regulation loop of long noncoding RNA HOTAIR and p53 in non-small-cell lung cancer

Zhai N, Xia Y, Yin R, Liu J, Gao F

OncoTargets and Therapy 2016, 9:5713-5720

Published Date: 16 September 2016

Identifying module biomarkers from gastric cancer by differential correlation network

Liu X, Chang X

OncoTargets and Therapy 2016, 9:5701-5711

Published Date: 19 September 2016

Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients [Retraction]

Wang Y, Cheng Y, Yu G, Jia B, Hu Z, Zhang L

OncoTargets and Therapy 2016, 9:5699-5700

Published Date: 20 September 2016

MicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinoma

Lin K, Xu T, He BS, Pan YQ, Sun HL, Peng HX, Hu XX, Wang SK

OncoTargets and Therapy 2016, 9:5679-5692

Published Date: 15 September 2016

Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma

Doan HQ, Silapunt S, Migden MR

OncoTargets and Therapy 2016, 9:5671-5678

Published Date: 14 September 2016

Primary gastric anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma

Tian C, Zhang Y

OncoTargets and Therapy 2016, 9:5659-5661

Published Date: 13 September 2016

A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass

Takatori E, Shoji T, Takada A, Nagasawa T, Omi H, Kagabu M, Honda T, Miura F, Takeuchi S, Sugiyama T

OncoTargets and Therapy 2016, 9:5651-5657

Published Date: 13 September 2016

The association of PTEN hypermethylation and breast cancer: a meta-analysis

Luo S, Chen J, Mo X

OncoTargets and Therapy 2016, 9:5643-5650

Published Date: 12 September 2016

Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms

Ko SH, Baeg MK, Bae WJ, Kim P, Choi MG

OncoTargets and Therapy 2016, 9:5611-5617

Published Date: 9 September 2016

Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients

Suner A, Buyukhatipoglu H, Aktas G, Kus T, Ulaslı M, Oztuzcu S, Kalender ME, Sevinc A, Kul S, Camci C

OncoTargets and Therapy 2016, 9:5603-5609

Published Date: 9 September 2016

Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma

Wang J, Liu F, Ao P, Li X, Zheng H, Wu D, Zhang N, She J, Yuan J, Wu X

OncoTargets and Therapy 2016, 9:5597-5602

Published Date: 9 September 2016

Proton therapy for early stage prostate cancer: is there a case?

Chan TY, Tan PW, Tang JI

OncoTargets and Therapy 2016, 9:5577-5586

Published Date: 9 September 2016

The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis

Wei BJ, Yao MY, Xing CY, Wang W, Yao J, Hong Y, Liu Y, Fu PF

OncoTargets and Therapy 2016, 9:5567-5575

Published Date: 8 September 2016

Accelerated partial breast irradiation in an Asian population: dosimetric findings and preliminary results of a multicatheter interstitial program

Koh YV, Tan PW, Buhari SA, Iau P, Chan CW, Shen L, Tan SH, Tang JI

OncoTargets and Therapy 2016, 9:5561-5566

Published Date: 8 September 2016

Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer

Xian Y, Zhang S, Wang X, Qin J, Wang W, Wu H

OncoTargets and Therapy 2016, 9:5553-5560

Published Date: 7 September 2016

Novel chlorambucil-conjugated anionic linear-globular PEG-based second-generation dendrimer: in vitro/in vivo improved anticancer activity

Assadi A, Najafabadi VS, Shandiz SAS, Boroujeni AS, Ashrafi S, Vaziri AZ, Ghoreishi SM, Aghasadeghi MR, Ebrahimi SES, Pirali-Hamedani M, Ardestani MS

OncoTargets and Therapy 2016, 9:5531-5543

Published Date: 7 September 2016

Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980–2013): an analysis of population-based data in relation to socio-economic changes

Banas T, Juszczyk G, Pitynski K, Nieweglowska D, Ludwin A, Czerw A

OncoTargets and Therapy 2016, 9:5521-5530

Published Date: 7 September 2016

Polymorphisms in the XPC gene and gastric cancer susceptibility in a Southern Chinese population

Hua RX, Zhuo ZJ, Shen GP, Zhu J, Zhang SD, Xue WQ, Li XZ, Zhang PF, He J, Jia WH

OncoTargets and Therapy 2016, 9:5513-5519

Published Date: 7 September 2016

Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report

Garcia-Recio M, Martinez-Serra J, Bento L, Ramos R, Gines J, Daumal J, Sampol A, Gutierrez A

OncoTargets and Therapy 2016, 9:5507-5511

Published Date: 7 September 2016

Sunitinib: the antiangiogenic effects and beyond

Hao Z, Sadek I

OncoTargets and Therapy 2016, 9:5495-5505

Published Date: 8 September 2016

Osimertinib making a breakthrough in lung cancer targeted therapy

Zhang H

OncoTargets and Therapy 2016, 9:5489-5493

Published Date: 6 September 2016

Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancers

Jin CY, Zhang XY, Sun M, Zhang YF, Zhang GX, Wang B

OncoTargets and Therapy 2016, 9:5483-5488

Published Date: 6 September 2016

Association between insulin-like growth factor-binding protein-3 polymorphism -202 A/C and the risk of prostate cancer: a meta-analysis

Qin Z, Li X, Tang J, Jiang X, Yu Y, Wang C, Xu W, Hua Y, Yu B, Zhang W

OncoTargets and Therapy 2016, 9:5451-5459

Published Date: 6 September 2016

Identifying candidate agents for lung adenocarcinoma by walking the human interactome

Sun Y, Zhang R, Jiang Z, Xia R, Zhang J, Liu J, Chen F

OncoTargets and Therapy 2016, 9:5439-5450

Published Date: 1 September 2016

Clinical potential of necitumumab in non-small cell lung carcinoma

Genova C, Hirsch FR

OncoTargets and Therapy 2016, 9:5427-5437

Published Date: 31 August 2016

Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example

Gerratana L, De Maglio G, De Pellegrin A, Follador A, Rihawi K, Pizzolitto S, Puglisi F, Fasola G

OncoTargets and Therapy 2016, 9:5399-5404

Published Date: 30 August 2016

Long-term results of definitive concurrent chemoradiotherapy using S-1 in the treatment of geriatric patients with esophageal cancer

Lv S, Fang M, Yang J, Zhan W, Jia Y, Xu H, Song T

OncoTargets and Therapy 2016, 9:5389-5397

Published Date: 6 September 2016

Pitavastatin suppressed liver cancer cells in vitro and in vivo

You HY, Zhang WJ, Xie XM, Zheng ZH, Zhu HL, Jiang FZ

OncoTargets and Therapy 2016, 9:5383-5388

Published Date: 29 August 2016

Verteporfin, a suppressor of YAP–TEAD complex, presents promising antitumor properties on ovarian cancer

Feng J, Gou J, Jia J, Yi T, Cui T, Li Z

OncoTargets and Therapy 2016, 9:5371-5381

Published Date: 29 August 2016

Limb-salvage treatment of en-block resected distal femoral tumors with endoprosthesis of all-polyethylene tibial component: a 9-year follow-up study

Tang F, Zhou Y, Min L, Zhang WL, Shi R, Luo Y, Duan H, Tu CQ

OncoTargets and Therapy 2016, 9:5361-5369

Published Date: 13 September 2016

ALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway

Jiang J, Liu Y, Tang Y, Li L, Zeng R, Zeng S, Zhong M

OncoTargets and Therapy 2016, 9:5349-5360

Published Date: 29 August 2016

Knockdown of peroxisome proliferator-activated receptor gamma coactivator-1 alpha increased apoptosis of human endometrial cancer HEC-1A cells

Yang H, Yang R, Liu H, Ren Z, Wang C, Li D, Ma X

OncoTargets and Therapy 2016, 9:5329-5338

Published Date: 24 August 2016

Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma

Deng Y, Pang Q, Miao RC, Chen W, Zhou YY, Bi JB, Liu SS, Zhang JY, Qu K, Liu C

OncoTargets and Therapy 2016, 9:5317-5328

Published Date: 24 August 2016

Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma

Lin DZ, Qu N, Shi RL, Lu ZW, Ji QH, Wu WL

OncoTargets and Therapy 2016, 9:5307-5316

Published Date: 24 August 2016

Knockdown of Sall4 inhibits intrahepatic cholangiocarcinoma cell migration and invasion in ICC-9810 cells

Zhu L, Huang FZ, Deng G, Nie W, Huang W, Xu HB, Zheng SP, Yi ZJ, Wan T

OncoTargets and Therapy 2016, 9:5297-5305

Published Date: 24 August 2016

Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1

Nakahara Y, Takagi Y, Hosomi Y, Kagei A, Yamamoto T, Sawada T, Yomota M, Okuma Y, Mikura S, Okamura T

OncoTargets and Therapy 2016, 9:5287-5295

Published Date: 24 August 2016

Expression and prognostic significance of unique ULBPs in pancreatic cancer

Chen J, Zhu XX, Xu H, Fang HZ, Zhao JQ

OncoTargets and Therapy 2016, 9:5271-5279

Published Date: 25 August 2016

Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma

Guo HS, Xing YH, Mu AL, Li X, Li TS, Bian X, Yang CM, Zhang XL, Liu YF, Wang XG

OncoTargets and Therapy 2016, 9:5257-5270

Published Date: 25 August 2016

MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer

Liu D, Xia H, Wang F, Chen C, Long J

OncoTargets and Therapy 2016, 9:5245-5255

Published Date: 23 August 2016

Prognostic significance of TAZ expression in various cancers: a meta-analysis

Feng J, Ren P, Gou J, Li Z

OncoTargets and Therapy 2016, 9:5235-5244

Published Date: 23 August 2016

Association between BHMT gene rs3733890 polymorphism and cancer risk: evidence from a meta-analysis

Xu Y, Yan C, Hao Z, Zhou J, Fan S, Tai S, Yang C, Zhang L, Liang C

OncoTargets and Therapy 2016, 9:5225-5233

Published Date: 22 August 2016

Surgical procedures for papillary thyroid carcinoma located in the thyroid isthmus: an intention-to-treat analysis

Lei JY, Zhu JQ, Li ZH, Gong RX, Wei T

OncoTargets and Therapy 2016, 9:5209-5216

Published Date: 22 August 2016

Effect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKT

Zhang Y, Huang SN, Leng YH, Chen X, Liu TT, Wang HL, Wei FL, Luo DZ, Chen G, Wei ZX

OncoTargets and Therapy 2016, 9:5195-5202

Published Date: 29 August 2016

Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study

Huang WT, Wang HL, Yang H, Ren FH, Luo YH, Huang CQ, Liang YY, Liang HW, Chen G, Dang YW

OncoTargets and Therapy 2016, 9:5163-5180

Published Date: 22 August 2016

Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma

Qu Z, Yuan CH, Yin CQ, Guan Q, Chen H, Wang FB

OncoTargets and Therapy 2016, 9:5143-5152

Published Date: 18 August 2016

Co-expression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance

Jia W, Wang W, Ji CS, Niu JY, Lv YJ, Zhou HC, Hu B

OncoTargets and Therapy 2016, 9:5133-5142

Published Date: 18 August 2016

Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinoma

Lv X, Xia WX, Ke LR, Yang J, Qiu WZ, Yu YH, Liang H, Huang XJ, Liu GY, Zeng Q, Guo X, Xiang YQ

OncoTargets and Therapy 2016, 9:5123-5131

Published Date: 18 August 2016

Immune checkpoint inhibitors: the new frontier in non–small cell lung cancer treatment

El-Osta HE, Shahid K, Mills GM, Peddi P

OncoTargets and Therapy 2016, 9:5101-5116

Published Date: 16 August 2016

MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK

Cheng Y, Zhang X, Li P, Yang C, Tang J, Deng X, Yang X, Tao J, Lu Q, Li P

OncoTargets and Therapy 2016, 9:5091-5099

Published Date: 16 August 2016

Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel

Kus T, Aktas G, Kalender ME, Demiryurek AT, Ulasli M, Oztuzcu S, Sevinc A, Kul S, Camci C

OncoTargets and Therapy 2016, 9:5073-5080

Published Date: 12 August 2016

Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis

Huang WT, Chen ZX, He RQ, Wu YZ, Yin SY, Liang XN, Chen G, Yang H, Peng ZG, Yang LH

OncoTargets and Therapy 2016, 9:5061-5071

Published Date: 12 August 2016

Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells

Liu P, Zhang H, Wu X, Guo L, Wang F, Xia G, Chen B, Yin H, Wang Y, Li X

OncoTargets and Therapy 2016, 9:5049-5059

Published Date: 12 August 2016

New utility of an old marker: serum low-density lipoprotein predicts histopathological response of neoadjuvant chemotherapy in locally advanced gastric cancer

Zhou JC, Guo JF, Teng RY, Wang QC, Wang J, Wei Q, Li ZD, Shen JG, Wang LB

OncoTargets and Therapy 2016, 9:5041-5047

Published Date: 12 August 2016

PD-L1 expression in human cancers and its association with clinical outcomes

Wang X, Teng FF, Kong L, Yu JM

OncoTargets and Therapy 2016, 9:5023-5039

Published Date: 12 August 2016

Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk model

Shi RL, Qu N, Yang SW, Ma B, Lu ZW, Wen D, Sun GH, Wang Y, Ji QH

OncoTargets and Therapy 2016, 9:5015-5022

Published Date: 12 August 2016

Long noncoding RNA ZNFX1-AS1 suppresses growth of hepatocellular carcinoma cells by regulating the methylation of miR-9

Wang T, Ma SC, Qi X, Tang X, Cui D, Wang Z, Chi J, Li P, Zhai B

OncoTargets and Therapy 2016, 9:5005-5014

Published Date: 12 August 2016

Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer

Wang SW, Ren J, Yan YL, Xue CF, Tan L, Ma XW

OncoTargets and Therapy 2016, 9:4993-5003

Published Date: 16 August 2016

Successful treatment of angiosarcoma of the scalp with apatinib: a case report

Ji G, Hong L, Yang P

OncoTargets and Therapy 2016, 9:4989-4992

Published Date: 11 August 2016

Clinical implications of transforming growth factor-beta–induced gene-h3 protein expression in lung cancer

He CJ, Sun DW, Bai X, Li YB, Xu H, Xu SD

OncoTargets and Therapy 2016, 9:4983-4987

Published Date: 11 August 2016

ATG7 promotes the tumorigenesis of lung cancer but might be dispensable for prognosis predication: a clinicopathologic study

Sun SX, Wang ZH, Tang F, Hu PC, Yang ZT, Xue C, Gong J, Shi L, Xie CH

OncoTargets and Therapy 2016, 9:4975-4981

Published Date: 11 August 2016

Anorectal melanoma metastatic to the breast: a case report and review of the literature

Feng L, Qi DJ, Zhang QF

OncoTargets and Therapy 2016, 9:4969-4974

Published Date: 10 August 2016

Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases

Zhang Y, Luo J, He RQ, Huang WT, Li ZY, Li P, Dang YW, Chen G, Li SK

OncoTargets and Therapy 2016, 9:4959-4968

Published Date: 10 August 2016

Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned

Pinilla-Ibarz J, Sweet KL, Corrales-Yepez GM, Komrokji RS

OncoTargets and Therapy 2016, 9:4937-4957

Published Date: 10 August 2016

Antihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant setting

Seber S, Solmaz D, Yetisyigit T

OncoTargets and Therapy 2016, 9:4929-4935

Published Date: 9 August 2016

A rare case report of primary bone lymphoma and a brief review of the literature

Wang J, Fan S, Liu J, Song B,

OncoTargets and Therapy 2016, 9:4923-4928

Published Date: 9 August 2016

Incidental gallbladder cancer after cholecystectomy: 1990 to 2014

Dorobisz T, Dorobisz K, Chabowski M, Pawłowski W, Janczak D, Patrzałek D, Janczak D

OncoTargets and Therapy 2016, 9:4913-4916

Published Date: 8 August 2016

High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway

Yang XY, Zhang MY, Zhou Q, Wu SY, Zhao Y, Gu WY, Pan J, Cen JN, Chen ZX, Guo WG, Chen CS, Yan WH, Hu SY

OncoTargets and Therapy 2016, 9:4887-4899

Published Date: 8 August 2016

A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

Zhu L, Li X, Shen Y, Cao Y, Fang X, Chen J, Yuan Y

OncoTargets and Therapy 2016, 9:4879-4886

Published Date: 8 August 2016

Modulation of expression of the nuclear receptor NR0B2 (small heterodimer partner 1) and its impact on proliferation of renal carcinoma cells

Prestin K, Olbert M, Hussner J, Isenegger TL, Gliesche DG, Böttcher K, Zimmermann U, Meyer zu Schwabedissen HE

OncoTargets and Therapy 2016, 9:4867-4878

Published Date: 8 August 2016

Salvage therapies in relapsed and/or refractory myeloma: what is current and what is the future?

Thumallapally N, Yu H, Asti D, Vennepureddy A, Terjanian T

OncoTargets and Therapy 2016, 9:4843-4858

Published Date: 5 August 2016

PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis

Qian D, Cheng J, Ding X, Chen X, Chen X, Guan Y, Zhang B, Wang J, Er P, Qiu M, Zeng X, Guo Y, Wang H, Zhao L, Xie D, Yuan Z, Wang P, Pang Q

OncoTargets and Therapy 2016, 9:4821-4831

Published Date: 3 August 2016

A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer

Karakas Y, Esin E, Lacin S, Ceyhan K, Heper AO, Yalcin S

OncoTargets and Therapy 2016, 9:4815-4820

Published Date: 3 August 2016

Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients

Gu X, Gao XS, Xiong W, Guo W, Han L, Bai Y, Peng C, Cui M, Xie M

OncoTargets and Therapy 2016, 9:4805-4813

Published Date: 2 August 2016

Cutaneous basal cell carcinoma arising within a keloid scar: a case report

Goder M, Kornhaber R, Bordoni D, Winkler E, Haik J, Tessone A

OncoTargets and Therapy 2016, 9:4793-4796

Published Date: 2 August 2016

Comparison of planning target volumes based on three-dimensional and four-dimensional CT imaging of thoracic esophageal cancer

Wang W, Li JB, Zhang YJ, Shao Q, Xu M, Fan TY, Wang JZ

OncoTargets and Therapy 2016, 9:4785-4791

Published Date: 2 August 2016

Induction of apoptosis by Armillaria mellea constituent armillarikin in human hepatocellular carcinoma

Chen YJ, Chen CC, Huang HL

OncoTargets and Therapy 2016, 9:4773-4783

Published Date: 1 August 2016

Docetaxel-loaded lipid microbubbles combined with ultrasound-triggered microbubble destruction for targeted tumor therapy in MHCC-H cells

Zhang Y, Chang R, Li MQ, Zhao K, Zheng HZ, Zhou XD

OncoTargets and Therapy 2016, 9:4763-4771

Published Date: 1 August 2016

Risk factors and patterns of lymph node involvement in primary gastric large B-cell lymphoma: implications for target definition

Zhang X, Wang P, Zhao L, Yuan Z, Wang P

OncoTargets and Therapy 2016, 9:4757-4762

Published Date: 29 July 2016

Oncological outcome after lung metastasis in patients presenting with localized chondrosarcoma at extremities: Tokai Musculoskeletal Oncology Consortium study

Nakamura T, Matsumine A, Yamada S, Tsukushi S, Kawanami K, Ohno T, Katagiri H, Sugiura H, Yamada K, Yamada Y, Sudo A, Nishida Y

OncoTargets and Therapy 2016, 9:4747-4751

Published Date: 29 July 2016

RBBP6: a potential biomarker of apoptosis induction in human cervical cancer cell lines

Moela P, Motadi LR

OncoTargets and Therapy 2016, 9:4721-4735

Published Date: 29 July 2016

Primary yolk sac tumor of the gluteus: a case report and literature review

Li B, Jiang QQ, Zhang ST, Zhou Y, Zhang QF, OuYang L

OncoTargets and Therapy 2016, 9:4715-4719

Published Date: 2 August 2016

MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4

Yu M, Lin Y, Zhou Y, Jin H, Hou B, Wu Z, Li Z, Jian Z, Sun J

OncoTargets and Therapy 2016, 9:4705-4714

Published Date: 29 July 2016

Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy

Nemecek R, Berkovcova J, Radova L, Kazda T, Mlcochova J, Vychytilova-Faltejskova P, Slaby O, Svoboda M

OncoTargets and Therapy 2016, 9:4695-4703

Published Date: 28 July 2016

The impact of the extent of surgical resection on survival of gastric cancer patients

Angelov KG, Vasileva MB, Grozdev KS, Toshev SY, Sokolov MB, Todorov GT

OncoTargets and Therapy 2016, 9:4687-4694

Published Date: 28 July 2016

Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma

Azzariti A, Brunetti O, Porcelli L, Graziano G, Iacobazzi RM, Signorile M, Scarpa A, Lorusso V, Silvestris N

OncoTargets and Therapy 2016, 9:4681-4686

Published Date: 28 July 2016

Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer

Liu C, Huang Z, Wang QS, Sun B, Ding LJ, Meng XY, Wu SK

OncoTargets and Therapy 2016, 9:4653-4660

Published Date: 27 July 2016

Clinical implication of long noncoding RNA 91H expression profile in osteosarcoma patients

Xia WK, Lin QF, Shen D, Liu ZL, Su J, Mao WD

OncoTargets and Therapy 2016, 9:4645-4652

Published Date: 26 July 2016

MiR-203 is involved in the laryngeal carcinoma pathogenesis via targeting VEGFA and Cox-2

Xu L, Shen B, Chen TT, Dong P

OncoTargets and Therapy 2016, 9:4629-4637

Published Date: 26 July 2016

Identification of crucial microRNAs and genes in hypoxia-induced human lung adenocarcinoma cells

Geng Y, Deng L, Su D, Xiao J, Ge D, Bao Y, Jing H

OncoTargets and Therapy 2016, 9:4605-4616

Published Date: 25 July 2016

Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma

Sun Y, Hou L, Yang Y, Xie H, Yang Y, Li Z, Zhao H, Gao W, Su B

OncoTargets and Therapy 2016, 9:4583-4591

Published Date: 25 July 2016

Network analysis reveals potential markers for pediatric adrenocortical carcinoma

Kulshrestha A, Suman S, Ranjan R

OncoTargets and Therapy 2016, 9:4569-4581

Published Date: 26 July 2016

Green synthesis, characterization, and anticancer activity of hyaluronan/zinc oxide nanocomposites

Namvar F, Azizi S, Rahman HS, Mohamad R, Rasedee A, Soltani M, Rahim RA

OncoTargets and Therapy 2016, 9:4549-4559

Published Date: 26 July 2016

Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies

Ma JT, Sun X, Huang LT, Xiong ZC, Yuan M, Zhang SL, Han CB

OncoTargets and Therapy 2016, 9:4517-4526

Published Date: 22 July 2016

MicroRNA-490 inhibits tumorigenesis and progression in breast cancer

Zhao L, Zheng XY

OncoTargets and Therapy 2016, 9:4505-4516

Published Date: 22 July 2016

Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studies

Jiang X, Zhang M, Bai XY, Li S, Wu H

OncoTargets and Therapy 2016, 9:4491-4503

Published Date: 22 July 2016

Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis

Luo T, Chen J, Liu JJ, Li H, You XM, Wang HL, Zhu SL, Li LQ

OncoTargets and Therapy 2016, 9:4483-4489

Published Date: 21 July 2016

Clinical significance of TIPE expression in gastric carcinoma

Hu R, Qiu X, Hong S, Meng L, Hong X, Qiu J, Yang J, Zhuang G, Liu Z

OncoTargets and Therapy 2016, 9:4473-4481

Published Date: 25 July 2016

Mast cells positive to tryptase, endothelial cells positive to protease-activated receptor-2, and microvascular density correlate among themselves in hepatocellular carcinoma patients who have undergone surgery

Ammendola M, Sacco R, Sammarco G, Piardi T, Zuccalà V, Patruno R, Zullo A, Zizzo N, Nardo B, Marech I, Crovace A, Gadaleta CD, Pessaux P, Ranieri G

OncoTargets and Therapy 2016, 9:4465-4471

Published Date: 21 July 2016

Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia

Chen YJ, Fang LW, Su WC, Hsu WY, Yang KC, Huang HL

OncoTargets and Therapy 2016, 9:4453-4464

Published Date: 20 July 2016

Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results

Pham PV, Le HT, Vu BT, Pham VQ, Le PM, Phan NLC, Trinh NV, Nguyen HTL, Nguyen ST, Nguyen TL, Phan NK

OncoTargets and Therapy 2016, 9:4441-4451

Published Date: 21 July 2016

Congenital anomalies of the genitourinary system can help in diagnosis of the primary site of metastatic cancer: a case report and a review of the literature

Deptala A, Romanowicz A, Czerw A, Walecki J, Rogowski W, Nasierowska-Guttmejer A

OncoTargets and Therapy 2016, 9:4435-4440

Published Date: 20 July 2016

JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway

Liu Y, Wang YR, Ding GH, Yang TS, Yao L, Hua J, He ZG, Qian MP

OncoTargets and Therapy 2016, 9:4425-4433

Published Date: 20 July 2016

Functions and mechanisms of long noncoding RNAs in lung cancer

Peng ZZ, Zhang CF, Duan CJ

OncoTargets and Therapy 2016, 9:4411-4424

Published Date: 20 July 2016

FAT10 is associated with the malignancy and drug resistance of non-small cell lung cancer

Xue F, Zhu L, Meng QW, Wang L, Chen XS, Zhao YB, Xing Y, Wang XY, Cai L

OncoTargets and Therapy 2016, 9:4397-4409

Published Date: 19 July 2016

The expression status of TRX, AR, and cyclin D1 correlates with clinicopathological characteristics and ER status in breast cancer

Huang WS, Nie WW, Zhang WW, Wang YR, Zhu A, Guan XX

OncoTargets and Therapy 2016, 9:4377-4385

Published Date: 19 July 2016

Coffee consumption and risk of hepatocellular carcinoma: a meta-analysis of eleven epidemiological studies

Bai K, Cai Q, Jiang Y, Lv L

OncoTargets and Therapy 2016, 9:4369-4375

Published Date: 19 July 2016

Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer

Ricciardi GR, Franchina T, Russo A, Schifano S, Ferraro G, Adamo V

OncoTargets and Therapy 2016, 9:4351-4355

Published Date: 21 July 2016

Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction

Lu X, Duan L, Xie H, Lu X, Lu D, Lu D, Jiang N, Chen Y

OncoTargets and Therapy 2016, 9:4343-4349

Published Date: 18 July 2016

Association between CD14 SNP -159 C/T and gastric cancer: an independent case–control study and an updated meta-analysis

Gong AM, Li XY, Xie YQ, Jia ZD, Li YX, Zou YY, Xu CQ, Wang ZY

OncoTargets and Therapy 2016, 9:4337-4342

Published Date: 18 July 2016

Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance

Pyszniak M, Tabarkiewicz J, Łuszczki JJ

OncoTargets and Therapy 2016, 9:4323-4336

Published Date: 18 July 2016

Lung cancer with concurrent EGFR mutation and ROS1 rearrangement: a case report and review of the literature

Zhu YC, Xu CW, Ye XQ, Yin MX, Zhang JX, Du KQ, Zhang ZH, Hu J

OncoTargets and Therapy 2016, 9:4301-4305

Published Date: 15 July 2016

Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma

Tang WW, Liu ZH, Yang TX, Wang HJ, Cao XF

OncoTargets and Therapy 2016, 9:4289-4293

Published Date: 14 July 2016

Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies

Wu JY, Hu LR, Chen MY, Cao WJ, Chen HC, He TP

OncoTargets and Therapy 2016, 9:4277-4288

Published Date: 14 July 2016

Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma

Sun P, Chen C, Zhang F, Yang H, Bi XW, An X, Wang FH, Jiang WQ

OncoTargets and Therapy 2016, 9:4257-4264

Published Date: 13 July 2016

Comparison of tumor markers using different detection devices [Retraction]

Tao R, Tu SH, Liu C, Yang Q, Zhu M, Shen JF

OncoTargets and Therapy 2016, 9:4255-4256

Published Date: 15 July 2016

Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus

Zhang YF, Wei W, Wang JH, Xu L, Jian PE, Xiao CZ, Zhong XP, Shi M, Guo RP

OncoTargets and Therapy 2016, 9:4239-4246

Published Date: 12 July 2016

Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo

Zhang H, Chen R, Yang S, Liu W, Li K, Zhang H, Zhu X, Chen B

OncoTargets and Therapy 2016, 9:4215-4224

Published Date: 11 July 2016

Survival prognostic factors for patients with synchronous brain oligometastatic non-small-cell lung carcinoma receiving local therapy

Bai H, Xu J, Yang H, Jin B, Lou Y, Wu D, Han B

OncoTargets and Therapy 2016, 9:4207-4213

Published Date: 11 July 2016

Decreased expression of SLC39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer

Xu XM, Wang CG, Zhu YD, Chen WH, Shao SL, Jiang FN, Liao QD

OncoTargets and Therapy 2016, 9:4197-4205

Published Date: 11 July 2016

Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation

Zhu Y, Li M, Kong L, Yu J

OncoTargets and Therapy 2016, 9:4187-4196

Published Date: 11 July 2016

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial

von Au A, Milloth E, Diel I, Stefanovic S, Hennigs A, Wallwiener M, Heil J, Golatta M, Rom J, Sohn C, Schneeweiss A, Schuetz F, Domschke C

OncoTargets and Therapy 2016, 9:4173-4180

Published Date: 8 July 2016

Polymorphism in IGFBP3 gene is associated with prostate cancer risk: an updated meta-analysis

Qie YK, Nian XW, Liu XS, Hu HL, Zhang CW, Xie LG, Han RF, Wu CL, Xu Y

OncoTargets and Therapy 2016, 9:4163-4171

Published Date: 7 July 2016

Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer

Teng Y, Wang ZT, Ma L, Zhang L, Guo Y, Gu M, Wang ZY, Wang Y, Yue W

OncoTargets and Therapy 2016, 9:4151-4162

Published Date: 7 July 2016

Fundamental effects of PD-1 antibody on the body: a brief report

Wang W, Liu B, Liu G, Guo W

OncoTargets and Therapy 2016, 9:4137-4141

Published Date: 7 July 2016

Long-term survival and prognosis for primary clear cell carcinoma of the liver after hepatectomy

Chen ZS, Zhu SL, Qi LN, Li LQ

OncoTargets and Therapy 2016, 9:4129-4135

Published Date: 6 July 2016

Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer

Liu H, Huang C, Wu L, Wen B

OncoTargets and Therapy 2016, 9:4121-4127

Published Date: 6 July 2016

Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer

Kotaka M, Ikeda F, Tsujie M, Yoshioka S, Nakamoto Y, Ishii T, Kyogoku T, Kato T, Tsuji A, Kobayashi M

OncoTargets and Therapy 2016, 9:4113-4120

Published Date: 7 July 2016

Targeted therapy for localized non-small-cell lung cancer: a review

Paleiron N, Bylicki O, André M, Rivière E, Grassin F, Robinet G, Chouaïd C

OncoTargets and Therapy 2016, 9:4099-4104

Published Date: 5 July 2016

The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases

Pieper CC, Meyer C, Sprinkart AM, Block W, Ahmadzadehfar H, Schild HH, Mürtz P, Kukuk GM

OncoTargets and Therapy 2016, 9:4089-4098

Published Date: 5 July 2016

LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo

Chen L, Yang HX, Xiao YB, Tang XX, Li YQ, Han QQ, Fu JP, Yang YY, Zhu YC

OncoTargets and Therapy 2016, 9:4075-4087

Published Date: 4 July 2016

Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis

De Santis S, Borghesi C, Ricciardi S, Giovannoni D, Fulvi A, Migliorino MR, Marcassa C

OncoTargets and Therapy 2016, 9:4043-4052

Published Date: 4 July 2016

Icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study

He W, Zhang Y, Xiong Y, Dai FJ, Fan QX

OncoTargets and Therapy 2016, 9:4037-4041

Published Date: 1 July 2016

Chromatin assembly factor 1, subunit A (P150) facilitates cell proliferation in human hepatocellular carcinoma

Xu M, Jia Y, Liu Z, Ding L, Tian R, Gu H, Wang Y, Zhang H, Tu K, Liu Q

OncoTargets and Therapy 2016, 9:4023-4035

Published Date: 1 July 2016

Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis

Wei B, Yang S, Zhang B, Feng Y

OncoTargets and Therapy 2016, 9:4015-4022

Published Date: 1 July 2016

ALK-positive anaplastic large cell lymphoma with soft tissue involvement in a young woman

Gao KH, Li HT, Huang CH, Li HZ, Fang J, Tian C

OncoTargets and Therapy 2016, 9:3993-3996

Published Date: 1 July 2016

Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancreatic stump and other stump

Zeng XL, Wang HH, Meng MB, Wu ZQ, Song YC, Zhuang HQ, Qian D, Li FT, Zhao LJ, Yuan ZY, Wang P

OncoTargets and Therapy 2016, 9:3985-3992

Published Date: 30 June 2016

Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway

Yang H, Yang R, Liu H,α Ren Z, Kong F, Li D, Ma X

OncoTargets and Therapy 2016, 9:3963-3973

Published Date: 30 June 2016

Pri-let-7a-1 rs10739971 polymorphism is associated with gastric cancer prognosis and might affect mature let-7a expression

Li Y, Xu Q, Liu J, He C, Yuan Q, Xing C, Yuan Y

OncoTargets and Therapy 2016, 9:3951-3962

Published Date: 4 July 2016

The roles of serum CXCL16 in circulating Tregs and gastrointestinal stromal tumor cells

Xing YN, Zhang JY, Xu HM

OncoTargets and Therapy 2016, 9:3939-3949

Published Date: 29 June 2016

Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma

Yan Y, Xie M, Zhang L, Zhou X, Xie H, Zhou L, Zheng S, Wang W

OncoTargets and Therapy 2016, 9:3925-3937

Published Date: 30 June 2016

Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review

Xia QS, Xu J, Chen HY, Gao YZ, Gong FL, Hu LY, Yang L

OncoTargets and Therapy 2016, 9:3917-3923

Published Date: 29 June 2016

Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma

Zhang B, Li R, Chang CX, Han Y, Shi SB, Tian J

OncoTargets and Therapy 2016, 9:3901-3906

Published Date: 29 June 2016

Association between pesticide exposure and risk of kidney cancer: a meta-analysis

Xie B, Hu YF, Liang Z, Liu B, Zheng XY, Xie LP

OncoTargets and Therapy 2016, 9:3893-3900

Published Date: 28 June 2016

Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysis

Zhang CX, Wang SY, Chen SQ, Yang SL, Wan L, Xiong B

OncoTargets and Therapy 2016, 9:3883-3891

Published Date: 27 June 2016

Internal mammary sentinel lymph node biopsy: abandon or persist?

Qiu PF, Liu YB, Wang YS

OncoTargets and Therapy 2016, 9:3879-3882

Published Date: 27 June 2016

The clinical significance of γ-catenin in acute myeloid leukemia

Xu J, Wu W, Shen W, Liu P

OncoTargets and Therapy 2016, 9:3861-3871

Published Date: 27 June 2016

Downregulation of human Wnt3 in gastric cancer suppresses cell proliferation and induces apoptosis

Wang HS, Nie XB, Wu RB, Yuan HW, Ma YH, Liu XL, Zhang JY, Deng XL, Na Q, Jin HY, Bian YC, Gao YM, Wang YD, Chen WD

OncoTargets and Therapy 2016, 9:3849-3860

Published Date: 27 June 2016

LXY6090 – a novel manassantin A derivative – limits breast cancer growth through hypoxia-inducible factor-1 inhibition

Lai F, Liu Q, Liu X, Ji M, Xie P, Chen X

OncoTargets and Therapy 2016, 9:3829-3840

Published Date: 24 June 2016

Prognostic significance of metastatic lymph node ratio in squamous cell carcinoma of the cervix

Li C, Liu WH, Cheng YF

OncoTargets and Therapy 2016, 9:3791-3797

Published Date: 23 June 2016

Percutaneous microwave ablation combined with synchronous transcatheter arterial chemoembolization for the treatment of colorectal liver metastases: results from a follow-up cohort

Wu ZB, Si ZM, Qian S, Liu LX, Qu XD, Zhou B, Zhang W, Wang GZ, Liu R, Wang JH

OncoTargets and Therapy 2016, 9:3783-3789

Published Date: 23 June 2016

Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case–control studies

Zhang M, Fang T, Wang K, Mei H, Lv Z, Wang F, Cai Z, Liang C

OncoTargets and Therapy 2016, 9:3727-3737

Published Date: 22 June 2016

Correlation of primary middle and distal esophageal cancers motion with surrounding tissues using four-dimensional computed tomography

Wang W, Li J, Zhang Y, Shao Q, Xu M, Guo B, Shang D

OncoTargets and Therapy 2016, 9:3705-3710

Published Date: 22 June 2016

Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment

Bonanno L, Zago G, Marulli G, Del Bianco P, Schiavon M, Pasello G, Polo V, Canova F, Tonetto F, Loreggian L, Rea F, Conte PF, Favaretto A

OncoTargets and Therapy 2016, 9:3671-3681

Published Date: 21 June 2016

Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study

Ma X, Wang J, Xu Y, Zhang W, Liu J, Cao X, He A, Wang F, Gu L, Lei B, Wang J

OncoTargets and Therapy 2016, 9:3661-3669

Published Date: 20 June 2016

Potential role of S-adenosylmethionine in osteosarcoma development

Shi H, Mu WD, Zhang B, Meng T, Zhang ST, Zhou DS

OncoTargets and Therapy 2016, 9:3653-3659

Published Date: 20 June 2016

MicroRNA-190 regulates FOXP2 genes in human gastric cancer

Jia WZ, Yu T, An Q, Yang H, Zhang Z, Liu X, Xiao G

OncoTargets and Therapy 2016, 9:3643-3651

Published Date: 20 June 2016

The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma

Shen ED, Liu B, Yu XS, Xiang ZF, Huang HY

OncoTargets and Therapy 2016, 9:3633-3642

Published Date: 20 June 2016

A systematic review and meta-analysis of the risk of diarrhea associated with vandetanib treatment in carcinoma patients

Huo Z, Yu S, Hong S, Cao X, Xiu L, Liao Z, Li Y, Xiao H

OncoTargets and Therapy 2016, 9:3621-3631

Published Date: 20 June 2016

Roles of microRNA-99 family in human glioma

Zhang MY, Guo Y, Wu J, Chen FH, Dai ZJ, Fan SS, Li PC, Song T

OncoTargets and Therapy 2016, 9:3613-3619

Published Date: 20 June 2016

XuefuZhuyu Tang exerts antitumor effects by inhibiting glioma cell metastasis and invasion via regulating tumor microenvironment

Liu JM, Zhang J, Huang LW, Zhu XH, Chen W, Hu P

OncoTargets and Therapy 2016, 9:3603-3612

Published Date: 17 June 2016

High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis

Chen XY, Ru GQ, Ma YY, Xie J, Chen WY, Wang HJ, Wang SB, Li L, Jin KT, He XL, Mou XZ

OncoTargets and Therapy 2016, 9:3595-3602

Published Date: 16 June 2016

MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by targeting the PTEN/AKT pathway

Zhang H, Cao H, Xu D, Zhu K

OncoTargets and Therapy 2016, 9:3579-3588

Published Date: 16 June 2016

1p/19q codeletion and RET rearrangements in small-cell lung cancer

Lu H, Xu H, Xie F, Qin J, Han N, Fan Y, Mao W

OncoTargets and Therapy 2016, 9:3571-3577

Published Date: 16 June 2016

Association between GSTP1 Ile105Val polymorphism and urinary system cancer risk: evidence from 51 studies

Zhang Y, Yuan Y, Chen Y, Wang Z, Li F, Zhao Q

OncoTargets and Therapy 2016, 9:3565-3569

Published Date: 15 June 2016

miR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1

Zhang C, Chen X, Chen X, Wang X, Ji A, Jiang L, Sang F, Li F

OncoTargets and Therapy 2016, 9:3555-3563

Published Date: 15 June 2016

Intensity-modulated radiotherapy for gliomas: dosimetric effects of changes in gross tumor volume on organs at risk and healthy brain tissue

Yang Z, Zhang Z, Wang X, Hu Y, Lyu Z, Huo L, Wei R, Fu J, Hong J

OncoTargets and Therapy 2016, 9:3545-3554

Published Date: 15 June 2016

MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor

Xiao Y, Tian Q, He J, Huang M, Yang C, Gong L

OncoTargets and Therapy 2016, 9:3535-3544

Published Date: 15 June 2016

Cigarette smoking and risk of adult glioma: a meta-analysis of 24 observational studies involving more than 2.3 million individuals

Li HX, Peng XX, Zong Q, Zhang K, Wang MX, Liu YZ, Han GL

OncoTargets and Therapy 2016, 9:3511-3523

Published Date: 14 June 2016

Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy

Jiang P, Wang P, Sun X, Yuan Z, Zhan R, Ma X, Li W

OncoTargets and Therapy 2016, 9:3501-3509

Published Date: 13 June 2016

PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis

Han F, Hu R, Yang H, Liu J, Sui J, Xiang X, Wang F, Chu L, Song S

OncoTargets and Therapy 2016, 9:3485-3492

Published Date: 13 June 2016

Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells

Liu Y, Sun B, Liu T, Zhao X, Wang X, Li Y, Meng J, Gu Q, Liu F, Dong X, Liu P, Sun R, Zhao N

OncoTargets and Therapy 2016, 9:3473-3484

Published Date: 13 June 2016

Transcription factor activity of estrogen receptor α activation upon nonylphenol or bisphenol A treatment enhances the in vitro proliferation, invasion, and migration of neuroblastoma cells

Ma H, Yao Y, Wang C, Zhang L, Cheng L, Wang Y, Wang T, Liang E, Jia H, Ye Q, Hou M, Feng F

OncoTargets and Therapy 2016, 9:3451-3463

Published Date: 13 June 2016

Administration of polysaccharide from Panax notoginseng prolonged the survival of H22 tumor-bearing mice

Li HY, Gu LL, Zhong YY, Chen YJ, Zhang L, Zhang AR, Sobol RW, Chen T, Li J

OncoTargets and Therapy 2016, 9:3433-3441

Published Date: 8 June 2016

GPR30 decreases with vascular aging and promotes vascular smooth muscle cells maintaining differentiated phenotype and suppressing migration via activation of ERK1/2

Huang F, Yin J, Li K, Li Y, Qi H, Fang L, Yuan C, Liu W, Wang M, Li X

OncoTargets and Therapy 2016, 9:3415-3422

Published Date: 7 June 2016

The prognostic roles of ALDH1 isoenzymes in gastric cancer

Li K, Guo X, Wang Z, Li X, Bu Y, Bai X, Zheng L, Huang Y

OncoTargets and Therapy 2016, 9:3405-3414

Published Date: 7 June 2016

CEBPA mutations in patients with de novo acute myeloid leukemia: data analysis in a Chinese population

Su L, Gao SJ, Liu XL, Tan YH, Wang L, Li W

OncoTargets and Therapy 2016, 9:3399-3403

Published Date: 3 June 2016

A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors

Jiang Z, Zhang J, Li Z, Liu Y, Wang D, Han G

OncoTargets and Therapy 2016, 9:3387-3398

Published Date: 3 June 2016

Normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumors

Pop LA, Pileczki V, Cojocneanu-Petric RM, Petrut B, Braicu C, Jurj AM, Buiga R, Achimas-Cadariu P, Berindan-Neagoe I

OncoTargets and Therapy 2016, 9:3369-3380

Published Date: 2 June 2016

Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression

Zhang W, Zhou H, Yu Y, Li J, Li H, Jiang D, Chen Z, Yang D, Xu Z, Yu Z

OncoTargets and Therapy 2016, 9:3359-3368

Published Date: 2 June 2016

Significant association between long non-coding RNA HOTAIR polymorphisms and cancer susceptibility: a meta-analysis

Zhang J, Liu X, You LH, Zhou RZ

OncoTargets and Therapy 2016, 9:3335-3343

Published Date: 1 June 2016

Synthetic treatment of intracranial peripheral primitive neuroectodermal tumor with multiple metastasis: a case report

Zhang Y, Li HS, Li ZJ, Liu M, Yang L, Fan LY, Huang CS, Li BS

OncoTargets and Therapy 2016, 9:3327-3333

Published Date: 2 June 2016

The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer

Choi YJ, Chang WJ, Shin SW, Park KH, Kim ST, Kim YH

OncoTargets and Therapy 2016, 9:3307-3312

Published Date: 1 June 2016

Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer

Qiao XJ, Zhai XR, Wang JH, Zhao XT, Yang XJ, Lv JL, Ma L, Zhang LN, Wang Y, Zhang SC, Yue WT

OncoTargets and Therapy 2016, 9:3299-3305

Published Date: 1 June 2016

Clinical significance of B7-H6 protein expression in astrocytoma

Guo JG, Guo CC, He ZQ, Liu ZG, Wang Y, Mou YG

OncoTargets and Therapy 2016, 9:3291-3297

Published Date: 31 May 2016

MiR-502-3P suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SET

Jin H, Yu M, Lin Y, Hou B, Wu Z, Li Z, Sun J

OncoTargets and Therapy 2016, 9:3281-3289

Published Date: 31 May 2016

Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma

Nema R, Vishwakarma S, Agarwal R, Panday RK, Kumar A

OncoTargets and Therapy 2016, 9:3269-3280

Published Date: 31 May 2016

The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis

Chen ZL, Shen YW, Li ST, Li CL, Zhang LX, Yang J, Lv M, Lin YY, Wang X, Yang J

OncoTargets and Therapy 2016, 9:3233-3247

Published Date: 30 May 2016

The evaluative value of Sema3C and MFN2 co-expression detected by immunohistochemistry for prognosis in hepatocellular carcinoma patients after hepatectomy

Feng X, Zhu K, Liu J, Chen J, Tang J, Liang Y, Jin R, Liang X, Cai X

OncoTargets and Therapy 2016, 9:3213-3221

Published Date: 30 May 2016

Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis

Chen XW, Zhao JH, Li AL, Gao P, Sun JX, Song YX, Liu JJ, Chen P, Wang ZN

OncoTargets and Therapy 2016, 9:3205-3212

Published Date: 27 May 2016

Delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a review

Zhao F, Li MH, Kong L, Zhang GL, Yu JM

OncoTargets and Therapy 2016, 9:3197-3204

Published Date: 27 May 2016

Profile of nivolumab in the treatment of metastatic squamous non-small-cell lung cancer

Ang YLE, Lim JS, Soo RA

OncoTargets and Therapy 2016, 9:3187-3195

Published Date: 30 May 2016

Clinical features and treatment of squamous cell carcinoma of the breast

Zhang XM, Zhang BZ, Zang FL, Zhao LJ, Yuan ZY, Wang P

OncoTargets and Therapy 2016, 9:3181-3185

Published Date: 27 May 2016

Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy

Chen Z, Huang K, Lu Z, Deng S, Xiong J, Huang J, Li X, Tang F, Wang Z, Sun H, Wang L, Zhou S, Wang X, Jia Y, Hu T, Gui J, Wan D, Ma D, Li S, Wang S

OncoTargets and Therapy 2016, 9:3171-3179

Published Date: 27 May 2016

Do signal transduction cascades influence survival in triple-negative breast cancer? A preliminary study

Mumm JN, Kölbl AC, Jeschke U, Andergassen U

OncoTargets and Therapy 2016, 9:3163-3169

Published Date: 26 May 2016

Anti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiency

Bian X, Wu P, Sha H, Qian H, Wang Q, Cheng L, Yang Y, Yang M, Liu B

OncoTargets and Therapy 2016, 9:3153-3162

Published Date: 27 May 2016

Effect of YAP1 silencing on esophageal cancer

Zhao J, Li X, Yang Y, Zhu D, Zhang C, Liu D, Wu K, Zhao S

OncoTargets and Therapy 2016, 9:3137-3146

Published Date: 26 May 2016

Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study [Corrigendum]

Gao S, Zhu G, Lin Y, Fan X, Qian P, Zhu J, Yu Y

OncoTargets and Therapy 2016, 9:3135-3136

Published Date: 27 May 2016

Prognostic significance of neutrophil-to-lymphocyte ratio in rectal cancer: a meta-analysis

Dong YW, Shi YQ, He LW, Su PZ

OncoTargets and Therapy 2016, 9:3127-3134

Published Date: 25 May 2016

MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1

Li Y, Zeng C, Tu M, Jiang W, Dai Z, Hu Y, Deng Z, Xiao W

OncoTargets and Therapy 2016, 9:3101-3111

Published Date: 24 May 2016

Analysis of prostate bed motion using an endorectal balloon and cone beam computed tomography during postprostatectomy radiotherapy

Joo JH, Kim YJ, Kim YS, Cho YP, Lee HY, Jeong CY, Kwak J, Cho BC

OncoTargets and Therapy 2016, 9:3095-3100

Published Date: 24 May 2016

Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301

Han K, Meng W, Zhang JJ, Zhou Y, Wang YL, Su Y, Lin SC, Gan ZH, Sun YN, Min DL

OncoTargets and Therapy 2016, 9:3085-3094

Published Date: 26 May 2016

Long noncoding RNA ANRIL could be transactivated by c-Myc and promote tumor progression of non-small-cell lung cancer

Lu Y, Zhou XH, Xu L, Rong CH, Shen C, Bian W

OncoTargets and Therapy 2016, 9:3077-3084

Published Date: 24 May 2016

Restoration of miR-20a expression suppresses cell proliferation, migration, and invasion in HepG2 cells

Chen GS, Zhou N, Li JQ, Li T, Zhang ZQ, Si ZZ

OncoTargets and Therapy 2016, 9:3067-3076

Published Date: 27 May 2016

URG4 expression is a novel prognostic factor for the progression of nasopharyngeal carcinoma and overall survival of patient

Yu G, Meng QX, Zhang T, Zeng C, He BF, Zhang SS

OncoTargets and Therapy 2016, 9:3059-3065

Published Date: 23 May 2016

Prognostic role of miR-9 expression in various human malignant neoplasms: a meta-analysis

Liu XD, Luo ZY, Peng HX, Jiang H, Xu L

OncoTargets and Therapy 2016, 9:3039-3047

Published Date: 23 May 2016

Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports

Sun HL, Pan YQ, He BS, Nie ZL, Lin K, Peng HX, Cho WC, Wang SK

OncoTargets and Therapy 2016, 9:3017-3023

Published Date: 20 May 2016

Targeting gastrointestinal stromal tumors: the role of regorafenib

Schroeder B, Li Z, Cranmer LD, Jones RL, Pollack SM

OncoTargets and Therapy 2016, 9:3009-3016

Published Date: 20 May 2016

Onivyde for the therapy of multiple solid tumors

Zhang H

OncoTargets and Therapy 2016, 9:3001-3007

Published Date: 20 May 2016

Association between cooking oil fume exposure and lung cancer among Chinese nonsmoking women: a meta-analysis

Xue Y, Jiang Y, Jin S, Li Y

OncoTargets and Therapy 2016, 9:2987-2992

Published Date: 19 May 2016

Integrated miRNA-risk gene-pathway pair network analysis provides prognostic biomarkers for gastric cancer

Cai H, Xu J, Han Y, Lu Z, Han T, Ding Y, Ma L

OncoTargets and Therapy 2016, 9:2975-2986

Published Date: 19 May 2016

Non-small-cell lung cancer cells combat epidermal growth factor receptor tyrosine kinase inhibition through immediate adhesion-related responses

Wang HY, Hsu MK, Wang KH, Tseng CP, Chen FC, Hsu JTA

OncoTargets and Therapy 2016, 9:2961-2973

Published Date: 19 May 2016

Low-grade nasopharyngeal papillary adenocarcinoma: a case report and review of the literature

Wang XL, Yan HJ, Luo YJ, Fan TY

OncoTargets and Therapy 2016, 9:2955-2959

Published Date: 18 May 2016

Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors

Wu X, Zhang H, Salmani JMM, Fu R, Chen B

OncoTargets and Therapy 2016, 9:2935-2943

Published Date: 17 May 2016

Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma

Xu J, Liu X, Yang S, Zhang X, Shi Y

OncoTargets and Therapy 2016, 9:2911-2917

Published Date: 17 May 2016

Antitumor effect of manumycin on colorectal cancer cells by increasing the reactive oxygen species production and blocking PI3K-AKT pathway

Zhang JY, Jiang H, Xie L, Hu J, Li L, Yang M, Cheng L, Liu BR, Qian XP

OncoTargets and Therapy 2016, 9:2885-2895

Published Date: 24 May 2016

Recent advancements in erythrocytes, platelets, and albumin as delivery systems

Xu PP, Wang RJ, Wang XH, Ouyang J

OncoTargets and Therapy 2016, 9:2873-2884

Published Date: 17 May 2016

miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma

Liu C, Li M, Hu Y, Shi N, Yu H, Liu H, Lian H

OncoTargets and Therapy 2016, 9:2865-2871

Published Date: 19 May 2016

Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway

Sun Y, Tao C, Huang X, He H, Shi H, Zhang Q, Wu H

OncoTargets and Therapy 2016, 9:2845-2853

Published Date: 12 May 2016

Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?

Shakespeare TP, Wilcox SW, Aherne NJ

OncoTargets and Therapy 2016, 9:2819-2824

Published Date: 11 May 2016

Sophoridinol derivative 05D induces tumor cells apoptosis by topoisomerase1-mediated DNA breakage

Zhao W, Zhang C, Bi C, Ye C, Song D, Liu X, Shao R

OncoTargets and Therapy 2016, 9:2805-2817

Published Date: 11 May 2016

Silencing of carboxypeptidase E inhibits cell proliferation, tumorigenicity, and metastasis of osteosarcoma cells

Fan SL, Li X, Li LM, Wang LG, Du ZZ, Yang Y, Zhao JS, Li Y

OncoTargets and Therapy 2016, 9:2795-2803

Published Date: 10 May 2016

Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors

Barth RF, Wu G, Meisen WH, Nakkula RJ, Yang W, Huo T, Kellough DA, Kaumaya P, Turro C, Agius LM, Kaur B

OncoTargets and Therapy 2016, 9:2769-2781

Published Date: 10 May 2016

Orbital metastasis as the initial presentation of lung adenocarcinoma: a case report

Sun LC, Qi YL, Sun XD, Yu JM, Meng X

OncoTargets and Therapy 2016, 9:2743-2748

Published Date: 9 May 2016

miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer

Molinari C, Salvi S, Foca F, Teodorani N, Saragoni L, Puccetti M, Passardi A, Tamberi S, Avanzolini A, Lucci E, Calistri D

OncoTargets and Therapy 2016, 9:2735-2742

Published Date: 6 May 2016

Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma

Banzi M, De Blasio S, Lallas A, Longo C, Moscarella E, Alfano R, Argenziano G

OncoTargets and Therapy 2016, 9:2725-2733

Published Date: 6 May 2016

Ruguo key genes and tumor driving factors identification of bladder cancer based on the RNA-seq profile

Zhang M, Li H, Zou D, Gao J

OncoTargets and Therapy 2016, 9:2717-2723

Published Date: 5 May 2016

A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy

Wang J, Tian Y, Tang Y, Wang X, Li N, Ren H, Fang H, Feng Y, Wang S, Song Y, Liu Y, Wang W, Li Y, Jin J

OncoTargets and Therapy 2016, 9:2701-2707

Published Date: 5 May 2016

HOXB7 as a promising molecular marker for metastasis in cancers: a meta-analysis

Liu FT, Ou YX, Zhang GP, Qiu C, Luo HL, Zhu PQ

OncoTargets and Therapy 2016, 9:2693-2699

Published Date: 6 May 2016

Shorter telomere length of T-cells in peripheral blood of patients with lung cancer

Qian Y, Ding T, Wei L, Cao S, Yang L

OncoTargets and Therapy 2016, 9:2675-2682

Published Date: 4 May 2016

Emerging treatment options for myelofibrosis: focus on pacritinib

Chow V, Weissman A, O’Connell CL, Mehrvar A, Akhtari M

OncoTargets and Therapy 2016, 9:2655-2665

Published Date: 4 May 2016

Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis

Liu YX, Wang XS, Wang YF, Hu XC, Yan JQ, Zhang YL, Wang W, Yang RJ, Feng YY, Gao SG, Feng XS

OncoTargets and Therapy 2016, 9:2649-2654

Published Date: 4 May 2016

miR-125b inhibited epithelialal–mesenchymal transition of triple-negative breast cancer by targeting MAP2K7

Hong LQ, Pan F, Jiang HF, Zhang LH, Liu YH, Cai CS, Hua CZ, Luo X, Sun JH, Chen ZJ

OncoTargets and Therapy 2016, 9:2639-2648

Published Date: 4 May 2016

Tissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer – a meta-analysis

Chen Z, Liu H, Jin W, Ding Z, Zheng S, Yu Y

OncoTargets and Therapy 2016, 9:2615-2624

Published Date: 4 May 2016

Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study

Lin KY, Cheng SM, Tsai SL, Tsai JY, Lin CH, Cheung CHA

OncoTargets and Therapy 2016, 9:2601-2613

Published Date: 3 May 2016

Correlation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcinoma patients

Tang Q, Hu QY, Piao YF, Hua YH

OncoTargets and Therapy 2016, 9:2585-2591

Published Date: 2 May 2016

Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches

Pathan AAK, Panthi B, Khan Z, Koppula PR, Alanazi MS, Sachchidanand, Parine NR, Chourasia M

OncoTargets and Therapy 2016, 9:2575-2584

Published Date: 2 May 2016

Stathmin1 increases radioresistance by enhancing autophagy in non-small-cell lung cancer cells

Zhang X, Ji JF, Yang Y, Zhang J, Shen LF

OncoTargets and Therapy 2016, 9:2565-2574

Published Date: 29 April 2016

Haploidentical hematopoietic stem cell transplantation without total body irradiation for pediatric acute leukemia: a single-center experience

Mu YS, Qin MQ, Wang B, Li SD, Zhu GH, Zhou X, Yang J, Wang K, Lin W, Zheng HY

OncoTargets and Therapy 2016, 9:2557-2563

Published Date: 2 May 2016

Prognostic significance of miR-126 in various cancers: a meta-analysis

Dong Y, Fu C, Guan H, Zhang Z, Zhou T, Li BS

OncoTargets and Therapy 2016, 9:2547-2555

Published Date: 28 April 2016

Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen

Salacz ME, Kast RE, Saki N, Brüning A, Karpel-Massler G, Halatsch ME

OncoTargets and Therapy 2016, 9:2535-2545

Published Date: 27 April 2016

Midazolam regulated caspase pathway, endoplasmic reticulum stress, autophagy, and cell cycle to induce apoptosis in MA-10 mouse Leydig tumor cells

So EC, Chen YC, Wang SC, Wu CC, Huang MC, Lai MS, Pan BS, Kang FC, Huang BM

OncoTargets and Therapy 2016, 9:2519-2533

Published Date: 27 April 2016

Paeoniflorin prevents hypoxia-induced epithelial–mesenchymal transition in human breast cancer cells

Zhou Z, Wang S, Song C, Hu Z

OncoTargets and Therapy 2016, 9:2511-2518

Published Date: 27 April 2016

Diagnostic value of BRAFV600E-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis

Su X, Jiang X, Xu X, Wang W, Teng X, Shao A, Teng L

OncoTargets and Therapy 2016, 9:2495-2509

Published Date: 27 April 2016

Tandem mass spectrometry-based newborn screening strategy could be used to facilitate rapid and sensitive lung cancer diagnosis

Huang T, Cao YF, Zeng J, Dong J, Sun XY, Chen JX, Gao P

OncoTargets and Therapy 2016, 9:2479-2487

Published Date: 26 April 2016

Serum biomarker panels for diagnosis of gastric cancer

Tong WH, Ye F, He L, Cui LF, Cui M, Hu Y, Li W, Jiang J, Zhang DY, Suo J

OncoTargets and Therapy 2016, 9:2455-2463

Published Date: 26 April 2016

Irreversible electroporation: state of the art

Wagstaff PGK, Buijs M, van den Bos W, de Bruin DM, Zondervan PJ, de la Rosette JJMCH, Laguna Pes MP

OncoTargets and Therapy 2016, 9:2437-2446

Published Date: 22 April 2016

Metadherin regulates epithelial–mesenchymal transition in carcinoma

Wang Z, Tang ZY, Yin Z, Wei YB, Liu LF, Yan B, Zhou KQ, Nian YQ, Gao YL, Yang JR

OncoTargets and Therapy 2016, 9:2429-2436

Published Date: 21 April 2016

Complete transthoracic resection of giant posterior mediastinal goiter: case report and review of surgical strategies

Zhao H, Ren D, Liu Y, Li X, Wu Y, Chen G, Chen J

OncoTargets and Therapy 2016, 9:2415-2419

Published Date: 22 April 2016

Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases

He YY, Sun WW, Wang Y, Ren SX, Li XF, Li JY, Rivard CJ, Zhou CC, Hirsch FR

OncoTargets and Therapy 2016, 9:2409-2414

Published Date: 21 April 2016

AEG-1 as a predictor of sensitivity to neoadjuvant chemotherapy in advanced epithelial ovarian cancer

Wang Y, Jin X, Song H, Meng F

OncoTargets and Therapy 2016, 9:2385-2392

Published Date: 20 April 2016

ROI for outlining an entire tumor is a reliable approach for quantification of lung cancer tumor vascular parameters using CT perfusion

Ma E, Ren A, Gao B, Yang M, Zhao Q, Wang W, Li K

OncoTargets and Therapy 2016, 9:2377-2384

Published Date: 27 April 2016

Vitamin D postpones the progression of epithelial ovarian cancer induced by 7, 12-dimethylbenz [a] anthracene both in vitro and in vivo

Liu LZ, Hu ZY, Zhang HM, Hou YF, Zhang ZL, Zhou GM, Li BY

OncoTargets and Therapy 2016, 9:2365-2375

Published Date: 19 April 2016

Oral vinorelbine: a feasible and safe partner for radiotherapy in the treatment of locally advanced non-small cell lung cancer

Perri F, Lazzari G, Della Vittoria Scarpati G, Silvano G

OncoTargets and Therapy 2016, 9:2359-2364

Published Date: 19 April 2016

Massive chest wall resection and reconstruction for malignant disease

Foroulis CN, Kleontas AD, Tagarakis G, Nana C, Alexiou I, Grosomanidis V, Tossios P, Papadaki E, Kioumis I, Baka S, Zarogoulidis P, Anastasiadis K

OncoTargets and Therapy 2016, 9:2349-2358

Published Date: 19 April 2016

The predictive and prognostic values of factors associated with visceral pleural involvement in resected lung adenocarcinomas

Zhang HB, Lu C, Lu YJ, Yu B, Lv FZ, Zhu ZH

OncoTargets and Therapy 2016, 9:2337-2348

Published Date: 20 April 2016

Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer

He Q, Xu Q, Wu W, Chen L, Sun W, Ying JE

OncoTargets and Therapy 2016, 9:2329-2335

Published Date: 20 April 2016

Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancer

Zheng WQ, Jiang CH, Li RF

OncoTargets and Therapy 2016, 9:2317-2327

Published Date: 18 April 2016

MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial–mesenchymal transition

Jiang SB, He XJ, Xia YJ, Hu WJ, Luo JG, Zhang J, Tao HQ

OncoTargets and Therapy 2016, 9:2305-2315

Published Date: 18 April 2016

Carvacrol suppresses proliferation and invasion in human oral squamous cell carcinoma

Dai W, Sun C, Huang S, Zhou Q

OncoTargets and Therapy 2016, 9:2297-2304

Published Date: 18 April 2016

Clinicopathological characteristics of patients with HER2-positive breast cancer and the efficacy of trastuzumab in the People’s Republic of China

Zhou P, Jiang YZ, Hu X, Sun W, Liu YR, Liu F, Luo RC, Shao ZM

OncoTargets and Therapy 2016, 9:2287-2295

Published Date: 18 April 2016

Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes

Sochacki AL, Fischer MA, Savona MR

OncoTargets and Therapy 2016, 9:2273-2286

Published Date: 15 April 2016

Smad3 and phospho-Smad3 are potential markers of invasive nonfunctioning pituitary adenomas

Liu C, Li Z, Wu D, Li C, Zhang Y

OncoTargets and Therapy 2016, 9:2265-2271

Published Date: 15 April 2016

DUSP4/MKP2 overexpression is associated with BRAFV600E mutation and aggressive behavior of papillary thyroid cancer

Ma B, Shi RL, Yang SW, Zhou L, Qu N, Liao T, Wang Y, Wang YL, Ji QH

OncoTargets and Therapy 2016, 9:2255-2263

Published Date: 15 April 2016

Esophageal cancer stem cells and implications for future therapeutics

Qian X, Tan C, Wang F, Yang B, Ge Y, Guan Z, Cai J

OncoTargets and Therapy 2016, 9:2247-2254

Published Date: 19 April 2016

Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma

Wu H, Shi XL, Zhang HJ, Song QJ, Yang XB, Hu WD, Mei GL, Chen X, Mao QS, Chen Z

OncoTargets and Therapy 2016, 9:2227-2236

Published Date: 18 April 2016

BC200 LncRNA a potential predictive marker of poor prognosis in esophageal squamous cell carcinoma patients

Zhao RH, Zhu CH, Li XK, Cao W, Zong H, Cao XG, Hu HY

OncoTargets and Therapy 2016, 9:2221-2226

Published Date: 15 April 2016

Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer

Fu X, Chen G, Cai ZD, Wang C, Liu ZZ, Lin ZY, Wu YD, Liang YX, Han ZD, Liu JC, Zhong WD

OncoTargets and Therapy 2016, 9:2211-2220

Published Date: 15 April 2016

Short- and long-term outcomes of laparoscopic surgery vs open surgery for transverse colon cancer: a retrospective multicenter study

Kim JW, Kim JY, Kang BM, Lee BH, Kim BC, Park JH

OncoTargets and Therapy 2016, 9:2203-2209

Published Date: 15 April 2016

Ectopic adrenocorticotropic hormone syndrome caused by neuroendocrine tumors of the thymus: 30-year experience with 16 patients at a single institute in the People’s Republic of China

Chen YY, Li SQ, Liu HS, Qin YZ, Li L, Huang C, Bi YL, Meng YX, He J, Zhou XY, Ma DJ

OncoTargets and Therapy 2016, 9:2193-2201

Published Date: 26 April 2016

Association between two interleukin-2 gene polymorphisms and cancer susceptibility: a meta-analysis

Zhang M, Tan X, Huang J, Xie L, Wang H, Shi J, Lu W, Lv Z, Mei H, Liang C

OncoTargets and Therapy 2016, 9:2181-2192

Published Date: 19 April 2016

Identification of HSPA8 as a candidate biomarker for endometrial carcinoma by using iTRAQ-based proteomic analysis

Shan N, Zhou W, Zhang S, Zhang Y

OncoTargets and Therapy 2016, 9:2169-2179

Published Date: 13 April 2016

Effects of exercise intervention in breast cancer survivors: a meta-analysis of 33 randomized controlled trails

Zhu G, Zhang X, Wang Y, Xiong H, Zhao Y, Sun F

OncoTargets and Therapy 2016, 9:2153-2168

Published Date: 13 April 2016

Metastasis-associated lung adenocarcinoma transcript 1 promotes the proliferation of chondro­sarcoma cell via activating Notch-1 signaling pathway

Xu FQ, Zhang ZQ, Fang YC, Li XL, Sun Y, Xiong CZ, Yan LQ, Wang Q

OncoTargets and Therapy 2016, 9:2143-2151

Published Date: 13 April 2016

Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinoma

Zeng FC, Zeng MQ, Huang L, Li YL, Gao BM, Chen JJ, Xue RZ, Tang ZY

OncoTargets and Therapy 2016, 9:2131-2141

Published Date: 12 April 2016

ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen

Sensorn I, Sukasem C, Sirachainan E, Chamnanphon M, Pasomsub E, Trachu N, Supavilai P, Pinthong D, Wongwaisayawan S

OncoTargets and Therapy 2016, 9:2121-2129

Published Date: 12 April 2016

Simple models based on gamma-glutamyl transpeptidase and platelets for predicting survival in hepatitis B-associated hepatocellular carcinoma

Pang Q, Bi JB, Wang ZX, Xu XS, Qu K, Miao RC, Chen W, Zhou YY, Liu C

OncoTargets and Therapy 2016, 9:2099-2109

Published Date: 12 April 2016

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes

Sun Y, Joks M, Xu LM, Chen XL, Qian D, You JQ, Yuan ZY

OncoTargets and Therapy 2016, 9:2069-2080

Published Date: 6 April 2016

Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects

Yu XJ, Li YL, Yu YD, Lei JH, Wan GX, Cao FJ

OncoTargets and Therapy 2016, 9:2049-2056

Published Date: 6 April 2016

Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma

Chen R, Allibone S, Bartlett NL, Brice P, Chen A, Pose K, Rich L, Bonthapally V, Garfin PM, Fanale M

OncoTargets and Therapy 2016, 9:2027-2034

Published Date: 6 April 2016

Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients

Wang Y, Cheng Y, Yu G, Jia B, Hu Z, Zhang L

OncoTargets and Therapy 2016, 9:1997-2005

Published Date: 5 April 2016

Detection of EML4-ALK fusion gene and features associated with EGFR mutations in Chinese patients with non-small-cell lung cancer

Wen MM, Wang XJ, Sun Y, Xia JH, Fan LB, Xing H, Zhang ZP, Li XF

OncoTargets and Therapy 2016, 9:1989-1995

Published Date: 5 April 2016

Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer

Ma YM, Zhao S

OncoTargets and Therapy 2016, 9:1981-1988

Published Date: 4 April 2016

Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis

Zhao XT, Liu FZ, Zhang Y, Li PH

OncoTargets and Therapy 2016, 9:1961-1968

Published Date: 4 April 2016

Profile of ramucirumab in the treatment of metastatic non-small-cell lung cancer

Cooper MR, Binkowski C, Hartung J, Towle J

OncoTargets and Therapy 2016, 9:1953-1960

Published Date: 4 April 2016

A genetic variant in large tumor suppressor kinase 2 of Hippo signaling pathway contributes to prognosis of hepatocellular carcinoma

Shen LL, Wen J, Zhao TT, Hu ZB, Song C, Gu DY, He ML, Lee NP, Xu Z, Chen JF

OncoTargets and Therapy 2016, 9:1945-1951

Published Date: 4 April 2016

Advances in targeted and immunobased therapies for colorectal cancer in the genomic era

Seow HF, Yip WK, Fifis T

OncoTargets and Therapy 2016, 9:1899-1920

Published Date: 31 March 2016

Prognostic significance of circulating tumor cells in esophageal carcinoma: a meta-analysis

Qiao GL, Qi WX, Jiang WH, Chen Y, Ma LJ

OncoTargets and Therapy 2016, 9:1889-1897

Published Date: 31 March 2016

Concurrent cisplatin-based chemoradiotherapy versus exclusive radiotherapy in high-risk cervical cancer: a meta-analysis

Meng XY, Liao Y, Liu XP, Li S, Shi MJ, Zeng XT

OncoTargets and Therapy 2016, 9:1875-1888

Published Date: 31 March 2016

Pragmatic medicine in solid cancer: a translational alternative to precision medicine

Brábek J, Rosel D, Fernandes M

OncoTargets and Therapy 2016, 9:1839-1855

Published Date: 5 April 2016

Influence of negative lymph node in No 7 on survival of patients with middle thoracic esophageal squamous cell carcinoma

Zhang JL, Heng XY, Luo Y, Fu QX, Li ZR, Che FY, Li BS

OncoTargets and Therapy 2016, 9:1831-1837

Published Date: 30 March 2016

Tumoral angiogenesis in both adrenal adenomas and nonadenomas: a promising computed tomography biomarker for diagnosis

Wang X, Li K, Sun H, Zhao J, Zhang Z, Zheng L, Li W, Bai R, Zhang G

OncoTargets and Therapy 2016, 9:1823-1830

Published Date: 30 March 2016

Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2

Liu J, Wang H, Wang Y, Li Z, Pan Y, Liu Q, Yang M, Wang J

OncoTargets and Therapy 2016, 9:1813-1822

Published Date: 29 March 2016

Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway

Zhang HJ, Tao J, Sheng L, Hu X, Rong RM, Xu M, Zhu TY

OncoTargets and Therapy 2016, 9:1801-1812

Published Date: 29 March 2016

Comorbidity as an independent prognostic factor in elderly patients with peripheral T-cell lymphoma

Zhao H, Wang T, Wang Y, Yu Y, Wang X, Zhao Z, Yang H, Yan B, Wu X, Da W, Zhang Y

OncoTargets and Therapy 2016, 9:1795-1799

Published Date: 24 March 2016

miR-98 functions as a tumor suppressor in salivary adenoid cystic carcinomas

Liu XN, Zhang WC, Guo H, Yue JL, Zhuo SS

OncoTargets and Therapy 2016, 9:1777-1786

Published Date: 23 March 2016

Tremelimumab: research and clinical development

Comin-Anduix B, Escuin-Ordinas H, Ibarrondo FJ

OncoTargets and Therapy 2016, 9:1767-1776

Published Date: 23 March 2016

A meta-analysis of clinical trials assessing the effect of radiofrequency ablation for breast cancer

Chen J, Zhang C, Li F, Xu L, Zhu H, Wang S, Liu X, Zha X, Ding Q, Ling L, Zhou W, Sun X

OncoTargets and Therapy 2016, 9:1759-1766

Published Date: 23 March 2016

Efficacy of multimodal treatment for leptomeningeal metastases in a lung cancer harboring an EGFR mutation

Morichika D, Kubo T, Gotoda H, Tamura T, Ohashi K, Hotta K, Tabata M, Kurozumi K, Tanimoto M, Kiura K

OncoTargets and Therapy 2016, 9:1753-1758

Published Date: 22 March 2016

Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes

Wang T, Liu Y, Zhou B, Wang Z, Liang NC, Zhang YD, Dong ZH, Li J

OncoTargets and Therapy 2016, 9:1735-1741

Published Date: 22 March 2016

Clinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosis

Li JJ, Liang L, Liu YR, Luo YH, Liang XN, Luo DZ, Feng ZB, Dang YW, Yang LH, Chen G

OncoTargets and Therapy 2016, 9:1721-1734

Published Date: 21 March 2016

The interleukin-18 gene promoter -607 A/C polymorphism contributes to non-small-cell lung cancer risk in a Chinese population

Jia YC, Zang AM, Jiao SC, Chen SM, Yan F

OncoTargets and Therapy 2016, 9:1715-1719

Published Date: 21 March 2016

Up-regulated expression of phospholipase C, β1 is associated with tumor cell proliferation and poor prognosis in hepatocellular carcinoma

Li J, Zhao X, Wang D, He W, Zhang S, Cao W, Huang Y, Wang L, Zhou S, Luo K

OncoTargets and Therapy 2016, 9:1697-1706

Published Date: 21 March 2016

Statin use and mortality of patients with prostate cancer: a meta-analysis

Meng Y, Liao YB, Xu P, Wei WR, Wang J

OncoTargets and Therapy 2016, 9:1689-1696

Published Date: 21 March 2016

Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis

Shen H, Zhan M, Wang W, Yang D, Wang J

OncoTargets and Therapy 2016, 9:1679-1688

Published Date: 22 March 2016

High expression of Sox10 correlates with tumor aggressiveness and poor prognosis in human nasopharyngeal carcinoma

Zhao Y, Liu ZG, Tang J, Zou RF, Chen XY, Jiang GM, Qiu YF, Wang H

OncoTargets and Therapy 2016, 9:1671-1677

Published Date: 21 March 2016

Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study

Gao S, Zhu G, Lin Y, Fan X, Qian P, Zhu J, Yu Y

OncoTargets and Therapy 2016, 9:1657-1670

Published Date: 21 March 2016

Upregulation of metastasis-associated gene 2 promotes cell proliferation and invasion in nasopharyngeal carcinoma

Wu MH, Ye XX, Deng XB, Wu YX, Li XF, Zhang L

OncoTargets and Therapy 2016, 9:1647-1656

Published Date: 18 March 2016

Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review

Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito KI, Tateishi A, Yoshizawa A, Takayama F

OncoTargets and Therapy 2016, 9:1641-1646

Published Date: 18 March 2016

miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1

Huang YW, Liu JT, Fan LL, Wang F, Yu HQ, Wei W, Sun GP

OncoTargets and Therapy 2016, 9:1623-1633

Published Date: 17 March 2016

The CT and US features of Ewing’s sarcoma/primary neuroectodermal tumor of the kidney: two case reports and review of literature

Zhang DF, Li ZH, Gao DP, Yang GJ, Ding YY, Wang GS, Dong XX

OncoTargets and Therapy 2016, 9:1599-1603

Published Date: 17 March 2016

Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma

Zhao J, Chen F, Zhou Q, Pan W, Wang X, Xu J, Ni L, Yang H

OncoTargets and Therapy 2016, 9:1589-1597

Published Date: 17 March 2016

The efficacy and safety of nivolumab in the treatment of advanced melanoma: a meta-analysis of clinical trials

Jin CH, Zhang XL, Zhao KL, Xu J, Zhao M, Xu XH

OncoTargets and Therapy 2016, 9:1571-1578

Published Date: 16 March 2016

Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data

Chen C, Zhang LG, Liu J, Han H, Chen N, Yao AL, Kang SS, Gao WX, Shen H, Zhang LJ, Li YP, Cao FH, Li ZG

OncoTargets and Therapy 2016, 9:1545-1557

Published Date: 16 March 2016

Comparison of single agent versus combined chemotherapy in previously treated patients with advanced urothelial carcinoma: a meta-analysis

Wu XJ, Zhi Y, He P, Zhou XZ, Zheng J, Chen ZW, Zhou ZS

OncoTargets and Therapy 2016, 9:1535-1543

Published Date: 15 March 2016

miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22

Xiao J, Li Y, Zhang W, Jiang Y, Du B, Tan Y

OncoTargets and Therapy 2016, 9:1525-1534

Published Date: 16 March 2016

Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma

Fu H, Ma C, Guan W, Cheng W, Feng F, Wang H

OncoTargets and Therapy 2016, 9:1519-1523

Published Date: 15 March 2016

Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor

Yang CJ, Tsai MJ, Hung JY, Tsai YM, Lee JY, Chou SH, Liu TC, Shen MC, Huang MS, Chong IW

OncoTargets and Therapy 2016, 9:1511-1518

Published Date: 15 March 2016

Association between APE1 Asp148Glu polymorphism and the risk of urinary cancers: a meta-analysis of 18 case–control studies

Zhong JH, Zhao Z, Liu J, Yu HL, Zhou JY, Shi R

OncoTargets and Therapy 2016, 9:1499-1510

Published Date: 15 March 2016

Prognostic role of hypoxia-inducible factor-1 alpha expression in osteosarcoma: a meta-analysis

Ren HY, Zhang YH, Li HY, Xie T, Sun LL, Zhu T, Wang SD, Ye ZM

OncoTargets and Therapy 2016, 9:1477-1487

Published Date: 14 March 2016

Effects of CYP3A5 genetic polymorphism and smoking on the prognosis of non-small-cell lung cancer

Jiang LP, Zhu ZT, He CY

OncoTargets and Therapy 2016, 9:1461-1469

Published Date: 14 March 2016

Antitumor activity of pluripotent cell-engineered vaccines and their potential to treat lung cancer in relation to different levels of irradiation

Zhang Y, Duan X, Zhang W, Wu A, Yang H, Wu D, Wei Y, Chen X

OncoTargets and Therapy 2016, 9:1425-1436

Published Date: 11 March 2016

The effect of antagonizing RGD-binding integrin activity in papillary thyroid cancer cell lines

Cheng W, Feng F, Ma C, Wang H

OncoTargets and Therapy 2016, 9:1415-1423

Published Date: 11 March 2016

Ovarian small-cell carcinoma hypercalcemic type successfully treated: a case report and literature review

Wang JJ, Liu Q, Wu N, Zhou XD, Wang H, Wang X, Tu P, Zhou XJ, Shi QL

OncoTargets and Therapy 2016, 9:1409-1414

Published Date: 11 March 2016

A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detection

Wang Q, Sun T, Cao Y, Gao P, Dong J, Fang Y, Fang Z, Sun X, Zhu Z

OncoTargets and Therapy 2016, 9:1389-1398

Published Date: 11 March 2016

Quantitative assessment of caveolin-1 G14713A polymorphism and cancer susceptibility in the Asian population

Tang JJ, Wang G, Li Q, Song RF

OncoTargets and Therapy 2016, 9:1381-1387

Published Date: 10 March 2016

Prognostic role of microRNA-150 in various carcinomas: a meta-analysis

Wang W, Wang X, Zhang Y, Wang D, Gao H, Wang L, Gao S

OncoTargets and Therapy 2016, 9:1371-1379

Published Date: 11 March 2016

Impact of the care provided by gynecologic oncologists on outcomes of cervical cancer patients treated with radical hysterectomy

Wu MF, Li J, Lu HW, Wang LJ, Zhang BZ, Lin ZQ

OncoTargets and Therapy 2016, 9:1361-1370

Published Date: 10 March 2016

Association of thymidylate synthase expression and clinical outcomes of gastric cancer patients treated with fluoropyrimidine-based chemotherapy: a meta-analysis

Gao YH, Cui JX, Xi HQ, Cai AZ, Shen WS, Li JY, Zhang KC, Wei B, Chen L

OncoTargets and Therapy 2016, 9:1339-1350

Published Date: 9 March 2016

Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma

Lu Z, Yao Y, Song Q, Yang J, Zhao X, Yang P, Kang J

OncoTargets and Therapy 2016, 9:1327-1337

Published Date: 9 March 2016

Diagnostic value of two-dimensional shear wave elastography in papillary thyroid microcarcinoma

Duan SB, Yu J, Li X, Han ZY, Zhai HY, Liang P

OncoTargets and Therapy 2016, 9:1311-1317

Published Date: 9 March 2016

Zinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer

Zhang Y, Liu G, Wu S, Jiang F, Xie J, Wang Y

OncoTargets and Therapy 2016, 9:1303-1310

Published Date: 29 March 2016

Role of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patients

Li MJ, He Q, Li M, Luo F, Guan YS

OncoTargets and Therapy 2016, 9:1291-1302

Published Date: 9 March 2016

Decreased apolipoprotein A-I level indicates poor prognosis in extranodal natural killer/T-cell lymphoma, nasal type

Quan Q, Chen Q, Chen P, Jiang L, Li T, Qiu H, Zhang B

OncoTargets and Therapy 2016, 9:1281-1290

Published Date: 14 March 2016

Association of OPN rs11730582 polymorphism with cancer risk: a meta-analysis

He LL, Wang Y

OncoTargets and Therapy 2016, 9:1275-1280

Published Date: 7 March 2016

The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis

Liu YL, Zhang HM, Pan HM, Bao YH, Xue J, Wang TC, Dong XC, Li XL, Bao HG

OncoTargets and Therapy 2016, 9:1241-1249

Published Date: 7 March 2016

MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1

He X, Wei Y, Wang Y, Liu L, Wang W, Li N

OncoTargets and Therapy 2016, 9:1231-1239

Published Date: 7 March 2016

Integrating subpathway analysis to identify candidate agents for hepatocellular carcinoma

Wang J, Li M, Wang Y, Liu X

OncoTargets and Therapy 2016, 9:1221-1230

Published Date: 7 March 2016

Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma

Shankar A, Borin TF, Iskander A, Varma NR, Achyut BR, Jain M, Mikkelsen T, Guo AM, Chwang WB, Ewing JR, Bagher-Ebadian H, Arbab AS

OncoTargets and Therapy 2016, 9:1205-1219

Published Date: 9 March 2016

The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer

Ding X, Qiu L, Zhang L, Xi J, Li D, Huang X, Zhao Y, Wang X, Sun Q

OncoTargets and Therapy 2016, 9:1189-1204

Published Date: 8 March 2016

Profile of farletuzumab and its potential in the treatment of solid tumors

Sato S, Itamochi H

OncoTargets and Therapy 2016, 9:1181-1188

Published Date: 7 March 2016

The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population

Sha N, Xu H, Chen T, Tian DW, Xie WQ, Xie LG, Zhang Y, Xing C, Liu XT, Shen ZH, Wu ZL, Hu HL, Wu CL

OncoTargets and Therapy 2016, 9:1175-1179

Published Date: 7 March 2016

Screening miRNAs for early diagnosis of colorectal cancer by small RNA deep sequencing and evaluation in a Chinese patient population

Wang X, Chen L, Jin H, Wang S, Zhang Y, Tang X, Tang G

OncoTargets and Therapy 2016, 9:1159-1166

Published Date: 7 March 2016

Association between L55M polymorphism in Paraoxonase 1 and cancer risk: a meta-analysis based on 21 studies

Chen L, Lu W, Fang L, Xiong H, Wu X, Zhang M, Wu S, Yu D

OncoTargets and Therapy 2016, 9:1151-1158

Published Date: 4 March 2016

Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization

Hu Y, Chen W, Chen S, Huang Z

OncoTargets and Therapy 2016, 9:1145-1149

Published Date: 3 March 2016

miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells

Zhang M, Dong BB, Lu M, Zheng MJ, Chen H, Ding JZ, Xu AM, Xu YH

OncoTargets and Therapy 2016, 9:1123-1133

Published Date: 3 March 2016

Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiforme

Kusumawidjaja G, Gan PZ, Ong WS, Teyateeti A, Dankulchai P, Tan DYH, Chua ET, Chua KL, Tham CK, Wong FY, Chua ML

OncoTargets and Therapy 2016, 9:1115-1122

Published Date: 2 March 2016

YAP induces cisplatin resistance through activation of autophagy in human ovarian carcinoma cells

Xiao L, Shi XY, Zhang Y, Zhu Y, Zhu L, Tian W, Zhu BK, Wei ZL

OncoTargets and Therapy 2016, 9:1105-1114

Published Date: 16 March 2016

Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase

Qin T, Zhou NN, Zeng YD, Dinglin XX, Zhao YY, Liu H, Chen LK

OncoTargets and Therapy 2016, 9:1095-1103

Published Date: 1 March 2016

Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma

Li GJ, Xu HW, Ji JJ, Yang F, Gao BQ

OncoTargets and Therapy 2016, 9:1085-1093

Published Date: 1 March 2016

SPAG9 is involved in hepatocarcinoma cell migration and invasion via modulation of ELK1 expression

Yan QY, Lou GH, Qian Y, Qin B, Xu XP, Wang YN, Liu YN, Dong XJ

OncoTargets and Therapy 2016, 9:1067-1075

Published Date: 1 March 2016

Feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a Phase II trial

Martínez E, Martínez M, Rico M, Hernández B, Casas F, Viñolas N, Pérez-Casas A, Dómine M, Mínguez J

OncoTargets and Therapy 2016, 9:1057-1066

Published Date: 1 March 2016

Polymorphisms of vitamin D receptor gene TaqI susceptibility of prostate cancer: a meta-analysis

Fei XW, Liu NN, Li HF, Shen YT, Guo JM, Wu ZQ

OncoTargets and Therapy 2016, 9:1033-1045

Published Date: 1 March 2016

Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment

Kashima J, Horio H, Okuma Y, Hosomi Y, Hishima T

OncoTargets and Therapy 2016, 9:1029-1032

Published Date: 29 February 2016

Quality of life of patients with lung cancer

Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A

OncoTargets and Therapy 2016, 9:1023-1028

Published Date: 29 February 2016

Overexpression of Livin promotes migration and invasion of colorectal cancer cells by induction of epithelial–mesenchymal transition via NF-κB activation

Ge Y, Cao XK, Wang DL, Sun W, Sun HL, Han B, Cui JP, Liu BL

OncoTargets and Therapy 2016, 9:1011-1021

Published Date: 29 February 2016

Orchestrating epigenetic roles targeting ocular tumors

Wen X, Lu L, Zhang H, Fan X

OncoTargets and Therapy 2016, 9:1001-1009

Published Date: 29 February 2016

The pro-apoptotic effects of TIPE2 on AA rat fibroblast-like synoviocytes via regulation of the DR5–caspase–NF-κB pathway in vitro

Shi C, Zhang S, Hong S, Pang J, Yesibulati Y, Yin P, Zhuang G

OncoTargets and Therapy 2016, 9:993-1000

Published Date: 29 February 2016

A comparative study of idarubicin 12 mg/m2 and 8 mg/m2 combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients

Zhou L, Liu X, Liu H, Zhu W, Cai X, Song K, Zheng C, Tang B, Sun Z

OncoTargets and Therapy 2016, 9:985-991

Published Date: 29 February 2016

Analyses of prognostic factors in cases of non-small cell lung cancer with multiple brain metastases

Gong X, Zhou D, Liang S, Zhou C

OncoTargets and Therapy 2016, 9:977-983

Published Date: 1 March 2016

Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer

Ma B, Ma Q, Wang H, Zhang G, Zhang H, Wang X

OncoTargets and Therapy 2016, 9:959-976

Published Date: 29 February 2016

Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer

Liu X, Xu P, Qiu H, Liu J, Chen S, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z, Sun X

OncoTargets and Therapy 2016, 9:949-958

Published Date: 26 February 2016

Recurrent squamous cell carcinoma of the skin treated successfully with single agent cetuximab therapy

Seber S, Gonultas A, Ozturk O, Yetisyigit T

OncoTargets and Therapy 2016, 9:945-948

Published Date: 25 February 2016

Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases

Wada Y, Takami Y, Tateishi M, Ryu T, Mikagi K, Saitsu H

OncoTargets and Therapy 2016, 9:937-943

Published Date: 25 February 2016

Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer

Shen YW, Zhang XM, Li ST, Lv M, Yang J, Wang F, Chen ZL, Wang BY, Li P, Chen L, Yang J

OncoTargets and Therapy 2016, 9:929-935

Published Date: 24 February 2016

Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer

Ławicki S, Zajkowska M, Głażewska EK, Będkowska GE, Szmitkowski M

OncoTargets and Therapy 2016, 9:911-919

Published Date: 24 February 2016

Association between three exonuclease 1 polymorphisms and cancer risks: a meta-analysis

Chen ZY, Zheng SR, Zhong JH, Zhuang XD, Zhou JY

OncoTargets and Therapy 2016, 9:899-910

Published Date: 23 February 2016

Arsenic trioxide inhibits viability and induces apoptosis through reactivating the Wnt inhibitor secreted frizzled related protein-1 in prostate cancer cells

Zheng L, Jiang H, Zhang ZW, Wang KN, Wang QF, Li QL, Jiang T

OncoTargets and Therapy 2016, 9:885-894

Published Date: 23 February 2016

Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients

Jiang C, Hu WM, Liao FX, Yang Q, Chen P, Rong YM, Guo GF, Yin CX, Zhang B, He WZ, Xia LP

OncoTargets and Therapy 2016, 9:877-883

Published Date: 23 February 2016

Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis

Qiang G, Liang C, Xiao F, Yu Q, Wen H, Song Z, Tian Y, Shi B, Guo Y, Liu D

OncoTargets and Therapy 2016, 9:869-876

Published Date: 22 February 2016

Type I enteropathy-associated T-cell lymphoma in the colon of a 29-year-old patient and a brief literature review

Zhang JC, Wang Y, Wang XF, Zhang FX

OncoTargets and Therapy 2016, 9:863-868

Published Date: 22 February 2016

Potential impact of 18FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus

Liu S, Zhu H, Li W, Zhang B, Ma L, Guo Z, Huang Y, Song P, Yu J, Guo H

OncoTargets and Therapy 2016, 9:855-862

Published Date: 22 February 2016

The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations

Zheng DF, Wang R, Zhang Y, Pan YJ, Cheng XH, Cheng C, Zheng SB, Li H, Gong RX, Li Y, Shen XX, Sun YH, Chen HQ

OncoTargets and Therapy 2016, 9:833-843

Published Date: 22 February 2016

Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasis

Xu T, Zong YY, Peng LP, Kong S, Zhou ML, Zou JQ, Liu JL, Miao RZ, Sun XC, Li LP

OncoTargets and Therapy 2016, 9:815-822

Published Date: 19 February 2016

Association of polymorphisms in WWOX gene with risk and outcome of osteosarcoma in a sample of the young Chinese population

Zhang N, Jiang Z, Ren W, Yuan L, Zhu Y

OncoTargets and Therapy 2016, 9:807-813

Published Date: 19 February 2016

Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia

Wu YJ, Wang H, Liang JH, Miao Y, Liu L, Qiu HR, Qiao C, Wang R, Li JY

OncoTargets and Therapy 2016, 9:797-805

Published Date: 18 February 2016

PBOV1 promotes prostate cancer proliferation by promoting G1/S transition

Pan TJ, Wu RP, Liu B, Wen HD, Tu Z, Guo J, Yang JR, Shen GQ

OncoTargets and Therapy 2016, 9:787-795

Published Date: 16 February 2016

Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma

Kaseb AO, Morris JS, Iwasaki M, Al-Shamsi HO, Raghav KP, Girard L, Cheung S, Nguyen V, Elsayes KM, Xiao L, Abdel-Wahab R, Shalaby AS, Hassan M, Hassabo HM, Wolff RA, Yao JC

OncoTargets and Therapy 2016, 9:773-780

Published Date: 15 February 2016

Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics

Yang F, Lyu SX, Dong SY, Liu YH, Zhang XH, Wang OC

OncoTargets and Therapy 2016, 9:761-772

Published Date: 12 February 2016

Association of polymorphisms hOGG1 rs1052133 and hMUTYH rs3219472 with risk of nasopharyngeal carcinoma in a Chinese population

Xie Y, Wu Y, Zhou X, Yao M, Ning S, Wei Z

OncoTargets and Therapy 2016, 9:755-760

Published Date: 12 February 2016

Effects of electromagnetic radiation exposure on bone mineral density, thyroid, and oxidative stress index in electrical workers

Kunt H, Şentürk İ, Gönül Y, Korkmaz M, Ahsen A, Hazman Ö, Bal A, Genç A, Songur A

OncoTargets and Therapy 2016, 9:745-754

Published Date: 12 February 2016

Primary renal carcinoid tumor: case report and review of the literature

Li B, Cui TY, Ban ZQ, Luo L, Sun LJ

OncoTargets and Therapy 2016, 9:741-743

Published Date: 23 February 2016

Monitoring cancer stem cells: insights into clinical oncology

Lin SC, Xu YC, Gan ZH, Han K, Hu HY, Yao Y, Huang MZ, Min DL

OncoTargets and Therapy 2016, 9:731-740

Published Date: 11 February 2016

Values of 99mTc-methoxyisobutylisonitrile imaging after first-time large-dose 131I therapy in treating differentiated thyroid cancer

Pan X, Duan D, Zhu Y, Pang H, Guan L, Lv Z

OncoTargets and Therapy 2016, 9:723-730

Published Date: 10 February 2016

Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight

Peddi P, Paryani B, Takalkar A, Bundrick P, Ponugupati J, Nair B, El-Osta H

OncoTargets and Therapy 2016, 9:705-709

Published Date: 9 February 2016

Long noncoding RNAs in gastric cancer: functions and clinical applications

Wang J, Sun J, Wang J, Song Y, Gao P, Shi J, Chen P, Wang Z

OncoTargets and Therapy 2016, 9:681-697

Published Date: 10 February 2016

Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation

Liu J, Xing L, Meng X, Yue J, Meng X, Xie P, Li X, Kong L, Yu J

OncoTargets and Therapy 2016, 9:671-679

Published Date: 5 February 2016

Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE review

Jeong S, Kim JH, Kim MG, Han N, Kim IW, Kim T, Oh JM

OncoTargets and Therapy 2016, 9:655-669

Published Date: 9 February 2016

Radix Tetrastigma hemsleyani flavone inhibits proliferation, migration, and invasion of human lung carcinoma A549 cells

Zhong LR, Zheng JX, Sun QQ, Wei KM, Hu YJ

OncoTargets and Therapy 2016, 9:635-641

Published Date: 4 February 2016

Potassium-3-beta-hydroxy-20-oxopregn-5-en-17-alpha-yl sulfate: a novel inhibitor of 78 kDa glucose-regulated protein

Mhaidat NM, Al-Balas QA, Alzoubi KH, AlEjielat RF

OncoTargets and Therapy 2016, 9:627-634

Published Date: 3 February 2016

Intracellular calcium is a target of modulation of apoptosis in MCF-7 cells in the presence of IgA adsorbed to polyethylene glycol

Honorio-França AC, Nunes GT, Fagundes DLG, Marchi PGF, Fernandes RTS, França JL, França-Botelho AC, Moraes LCA, Varotti FP, França EL

OncoTargets and Therapy 2016, 9:617-626

Published Date: 3 February 2016

Retraction

Gu J, Sun R, Shen S, Yu Z

OncoTargets and Therapy 2016, 9:615-616

Published Date: 4 February 2016

Retraction

Li JZ, Zhang Y, Wen B, Li M, Wang YJ

OncoTargets and Therapy 2016, 9:613-614

Published Date: 4 February 2016

Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study

Zhang Y, Xie LG, Chen T, Xie WQ, Wu ZL, Xu H, Xing C, Sha N, Shen ZH, Qie YK, Liu XT, Hu HL, Wu CL

OncoTargets and Therapy 2016, 9:605-611

Published Date: 28 January 2016

Advances in dosimetry and biological predictors of radiation-induced esophagitis

Yu Y, Guan H, Dong Y, Xing L, Li X

OncoTargets and Therapy 2016, 9:597-603

Published Date: 28 January 2016

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients

Wang H, Wang L, Lu Y, Chen XQ, Geng QR, Wang WD, Xia ZJ

OncoTargets and Therapy 2016, 9:587-595

Published Date: 28 January 2016

Correlation between XRCC1 Arg399Gln genetic polymorphisms and susceptibility to bladder cancer: a meta-analysis

Liu N, Fei X, Shen Y, Shi W, Ma J

OncoTargets and Therapy 2016, 9:579-586

Published Date: 28 January 2016

Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis

Zhang K, Zhang L, Zhou J, Hao Z, Fan S, Yang C, Liang C

OncoTargets and Therapy 2016, 9:567-577

Published Date: 27 January 2016

Biomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRAS

Liu J, Hu J, Cheng L, Ren W, Yang M, Liu B, Xie L, Qian X

OncoTargets and Therapy 2016, 9:557-565

Published Date: 27 January 2016

Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma

Lei ZG, Ren XH, Wang SS, Liang XH, Tang YL

OncoTargets and Therapy 2016, 9:545-555

Published Date: 27 January 2016

Conservative treatment of coexisting microinvasive squamous and adenocarcinoma of the cervix: report of two cases and literature review

Sopracordevole F, Di Giuseppe J, Cervo S, Buttignol M, Giorda G, Ciavattini A, Canzonieri V

OncoTargets and Therapy 2016, 9:539-544

Published Date: 27 January 2016

Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine

Wittke S, Baxmann S, Fahlenkamp D, Kiessig ST

OncoTargets and Therapy 2016, 9:523-537

Published Date: 27 January 2016

Oct-4 is associated with gastric cancer progression and prognosis

Jiang WL, Zhang PF, Li GF, Dong JH, Wang XS, Wang YY

OncoTargets and Therapy 2016, 9:517-522

Published Date: 27 January 2016

Long-term gene therapy with Del1 fragment using nonviral vectors in mice with explanted tumors

Kitano H, Mamiya A, Ishikawa T, Egoshi K, Kokubun S, Hidai C

OncoTargets and Therapy 2016, 9:503-516

Published Date: 25 January 2016

PD-1/PD-L1 blockades in non-small-cell lung cancer therapy

Jing W, Li MM, Zhang Y, Teng FF, Han AQ, Kong L, Zhu H

OncoTargets and Therapy 2016, 9:489-502

Published Date: 25 January 2016

Abnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer

Shao W, Wang Q, Wang F, Jiang Y, Xu M, Xu J

OncoTargets and Therapy 2016, 9:477-487

Published Date: 25 January 2016

Utility of blood procalcitonin concentration in the management of cancer patients with infections

Durnaś B, Wątek M, Wollny T, Niemirowicz K, Marzec M, Bucki R, Góźdź S

OncoTargets and Therapy 2016, 9:469-475

Published Date: 22 January 2016

Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis

Tang WW, Huang CW, Tang CY, Xu J, Wang HJ

OncoTargets and Therapy 2016, 9:455-460

Published Date: 22 January 2016

Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer

Ma B, Wang J, Song Y, Gao P, Sun J, Chen X, Yang Y, Wang Z

OncoTargets and Therapy 2016, 9:445-453

Published Date: 21 January 2016

Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis

Xu HX, Tian YJ, Yuan X, Liu Y, Wu H, Liu Q, Wu GS, Wu KM

OncoTargets and Therapy 2016, 9:431-444

Published Date: 21 January 2016

New developments in the management of chronic lymphocytic leukemia: role of ofatumumab

Laurenti L, Innocenti I, Autore F, Sica S, Efremov DG

OncoTargets and Therapy 2016, 9:421-429

Published Date: 20 January 2016

TDRG1 functions in testicular seminoma are dependent on the PI3K/Akt/mTOR signaling pathway

Wang Y, Gan Y, Tan Z, Zhou J, Kitazawa R, Jiang X, Tang Y, Yang J

OncoTargets and Therapy 2016, 9:409-420

Published Date: 20 January 2016

Polymorphisms in pre-miRNA genes and cooking oil fume exposure as well as their interaction on the risk of lung cancer in a Chinese nonsmoking female population

Yin Z, Li H, Cui Z, Ren Y, Li X, Wu W, Guan P, Qian B, Rothman N, Lan Q, Zhou B

OncoTargets and Therapy 2016, 9:395-401

Published Date: 19 January 2016

Expression and prognostic significance of contactin 1 in human hepatocellular carcinoma

Li GY, Huang M, Pan TT, Jia WD

OncoTargets and Therapy 2016, 9:387-394

Published Date: 19 January 2016

Cost-effectiveness of radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer

Chai YL, Wang J, Wang T, Shi F, Wang JQ, Su J, Yang YY, Zhou X, Ma HL, He B, Liu Z

OncoTargets and Therapy 2016, 9:349-354

Published Date: 19 January 2016

Knockdown of TMEM16A suppressed MAPK and inhibited cell proliferation and migration in hepatocellular carcinoma

Deng L, Yang J, Chen H, Ma B, Pan K, Su C, Xu F, Zhang J

OncoTargets and Therapy 2016, 9:325-333

Published Date: 14 January 2016

Single sternal metastasis due to malignant melanoma with unexpected long-term survival: a case report

Gogakos AS, Paliouras D, Asteriou C, Rallis T, Lazopoulos A, Chatzinikolaou F, Zissimopoulos A, Tsavlis D, Tsirgogianni K, Zarogoulidis K, Porpodis K, Tsakiridis K, Pitsiou G, Kioumis I, Karapantzos I, Karapantzou C, Sachpekidis N, Zarogoulidis P, Barbetakis N

OncoTargets and Therapy 2016, 9:321-323

Published Date: 18 January 2016

Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme

Hou AW, Zhao LZ, Zhao FZ, Wang WL, Niu JY, Li BX, Zhou ZJ, Zhu DY

OncoTargets and Therapy 2016, 9:315-320

Published Date: 13 January 2016

MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells

Ruan WD, Wang P, Feng S, Xue Y, Zhang B

OncoTargets and Therapy 2016, 9:303-313

Published Date: 18 January 2016

The amplification of 1q21 is an adverse prognostic factor in patients with multiple myeloma in a Chinese population

Yu W, Guo R, Qu X, Qiu H, Li J, Zhang R, Chen L

OncoTargets and Therapy 2016, 9:295-302

Published Date: 12 January 2016

WISP3 is highly expressed in a subset of colorectal carcinomas with a better prognosis

Lu Y, Wang X, Sun X, Feng W, Guo H, Tang C, Deng A, Bao Y

OncoTargets and Therapy 2016, 9:287-293

Published Date: 12 January 2016

Telomerase reverse transcriptase methylation predicts lymph node metastasis and prognosis in patients with gastric cancer

Wu Y, Li G, He D, Yang F, He G, He L, Zhang H, Deng Y, Fan M, Shen L, Zhou D, Zhang Z

OncoTargets and Therapy 2016, 9:279-286

Published Date: 11 January 2016

Polymorphisms in RAD51 and their relation with breast cancer in Saudi females

Tulbah S, Alabdulkarim H, Alanazi M, Parine NR, Shaik J, Pathan AA, Al-Amri A, Khan W, Warsy A

OncoTargets and Therapy 2016, 9:269-277

Published Date: 11 January 2016

ALK-positive anaplastic large cell lymphoma with prominent bone involvement in a 13-year-old boy

Tian C, Yu Y, Yang HL, Zhu L, Wang YF, Zhang YZ

OncoTargets and Therapy 2016, 9:265-268

Published Date: 11 January 2016

The synergistic anticancer effect of cisplatin combined with Oldenlandia diffusa in osteosarcoma MG-63 cell line in vitro

Pu F, Chen F, Lin S, Chen S, Zhang Z, Wang B, Shao Z

OncoTargets and Therapy 2016, 9:255-263

Published Date: 11 January 2016

Silencing of Foxp3 delays the growth of murine melanomas and modifies the tumor immunosuppressive environment

Franco-Molina MA, Miranda-Hernández DF, Mendoza-Gamboa E, Zapata-Benavides P, Coronado-Cerda EE, Sierra-Rivera CA, Saavedra-Alonso S, Taméz-Guerra RS, Rodríguez-Padilla C

OncoTargets and Therapy 2016, 9:243-253

Published Date: 12 January 2016

Overexpression of p53 activated by small activating RNA suppresses the growth of human prostate cancer cells

Ge Q, Wang C, Ruan Y, Chen Z, Liu J, Ye Z

OncoTargets and Therapy 2016, 9:231-241

Published Date: 8 January 2016

Association between polymorphisms in selected inflammatory response genes and the risk of prostate cancer

Chen J, Ying XM, Huang XM, Huang P, Yan SC

OncoTargets and Therapy 2016, 9:223-229

Published Date: 11 January 2016

Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients

Iliev R, Stanik M, Fedorko M, Poprach A, Vychytilova-Faltejskova P, Slaba K, Svoboda M, Fabian P, Pacik D, Dolezel J, Slaby O

OncoTargets and Therapy 2016, 9:217-222

Published Date: 8 January 2016

PI3K inhibitors as new cancer therapeutics: implications for clinical trial design

Massacesi C, Di Tomaso E, Urban P, Germa C, Quadt C, Trandafir L, Aimone P, Fretault N, Dharan B, Tavorath R, Hirawat S

OncoTargets and Therapy 2016, 9:203-210

Published Date: 7 January 2016

Bioinformatics analysis of hepatitis C virus genotype 2a-induced human hepatocellular carcinoma in Huh7 cells

Xu P, Wu M, Chen H, Xu J, Wu M, Li M, Qian F, Xu J

OncoTargets and Therapy 2016, 9:191-202

Published Date: 8 January 2016

Expression and clinical significance of Nectin-4 in hepatocellular carcinoma

Ma J, Sheng ZY, Lv Y, Liu WB, Yao QY, Pan TT, Xu ZJ, Zhang CH, Xu GL

OncoTargets and Therapy 2016, 9:183-190

Published Date: 6 January 2016

The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis

Xie FJ, Lu HY, Zheng QQ, Qin J, Gao Y, Zhang YP, Hu X, Mao WM

OncoTargets and Therapy 2016, 9:171-181

Published Date: 6 January 2016

Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review

Cao Y, Zhu LZ, Jiang MJ, Yuan Y

OncoTargets and Therapy 2016, 9:149-158

Published Date: 31 December 2015

Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients

Li Z, Ma YY, Wang J, Zeng XF, Li R, Kang W, Hao XK

OncoTargets and Therapy 2016, 9:139-148

Published Date: 31 December 2015

Detection of lung adenocarcinoma with ROS1 rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic features

Cao B, Wei P, Liu Z, Bi R, Lu Y, Zhang L, Zhang J, Yang Y, Shen C, Du X, Zhou X

OncoTargets and Therapy 2016, 9:131-138

Published Date: 31 December 2015

High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy

Wang CY, Fu XL, Cai XW, Wu XH, Hu XC, Fan M, Xiang JQ, Zhang YW, Chen HQ, Jiang GL, Zhao KL

OncoTargets and Therapy 2016, 9:117-122

Published Date: 30 December 2015

Dairy consumption and lung cancer risk: a meta-analysis of prospective cohort studies

Yu Y, Li H, Xu K, Li X, Hu C, Wei H, Zeng X, Jing X

OncoTargets and Therapy 2016, 9:111-116

Published Date: 30 December 2015

MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1

Lu Y, Hu JJ, Sun W, Li S, Deng S, Li M

OncoTargets and Therapy 2016, 9:99-109

Published Date: 30 December 2015

Association between promoter polymorphisms of OPN gene and cancer risk: a meta-analysis

Liu JW, He CY, Yuan Q, Wang ZN, Xing CZ, Yuan Y

OncoTargets and Therapy 2016, 9:87-97

Published Date: 30 December 2015

Prognostic value of lymph node ratio in patients with small-cell carcinoma of the cervix based on data from a large national registry

Zhou J, Sun JY, Chen SY, Li FY, Lin HX, Wu SG, He ZY

OncoTargets and Therapy 2016, 9:67-73

Published Date: 23 December 2015

Genetic variants in insulin-like growth factor binding protein-3 are associated with prostate cancer susceptibility in Eastern Chinese Han men

Zhang G, Zhu Y, Liu F, Gu CY, Chen H, Xu JF, Ye DW

OncoTargets and Therapy 2016, 9:61-66

Published Date: 22 December 2015

Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis

Teng JJ, Zhang J, Zhang TY, Zhang S, Li BS

OncoTargets and Therapy 2016, 9:37-47

Published Date: 21 December 2015

Expression of interleukin 1β in gastric cancer tissue and its effects on gastric cancer

Yin S, Lan C, Pei H, Zhu Z

OncoTargets and Therapy 2016, 9:31-35

Published Date: 21 December 2015

Dendrobium candidum inhibits MCF-7 cells proliferation by inducing cell cycle arrest at G2/M phase and regulating key biomarkers

Sun J, Guo Y, Fu XQ, Wang YS, Liu Y, Huo B, Sheng J, Hu X

OncoTargets and Therapy 2016, 9:21-30

Published Date: 21 December 2015

Clinical efficacy of computed tomography-guided iodine-125 seed implantation therapy in patients with advanced spinal metastatic tumors

Zhang LY, Lu J, Wang ZM, Cheng YS, Teng GJ, Chen KM

OncoTargets and Therapy 2016, 9:7-12

Published Date: 18 December 2015